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in front of me. My grandpa passed away many years ago but I learned during my
PhD that he had an abdominal aortic aneurysm at the time of his unexpected
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iv

ACKNOWLEDGMENTS
There are several people who have contributed to the work presented here. In
particular, I want to thank past and current members of the CardioVascular Imaging
Research Laboratory as well as Drs. Paolo Di Achille and Matthew Bersi (formerly
at Yale), and Dr. Jay Humphrey (Yale). Students and PIs of several other labs have
provided me invaluable hands on assistance and advice: Dr. Tami Kinzer-Ursem and
Dr. Jackie Linnes (our third ﬂoor BME neighbors), Dr. Ji-Xin Cheng (basement BME
neighbor), Dr. Sarah Calve (BME), Drs. Ryan Grant and Jessie Ellis (Nutrition),
and Dr. Abigail Durkes (Comparative Pathobiology). I also want to acknowledge the
time and eﬀort by the exceptional staﬀ at the Purdue Histology Research Laboratory
(Victor Bernal-Crespo and Gabrielle Shafer) and Purdue Genomics Core Facility (Dr.
Phillip San Miguel, Paul Parker, and Viktoria Krasnyanskaya).

v

PREFACE
Two chapters of this dissertation (Chapters 4 and 5) have been published in peerreviewed journals as noted at the start of those chapters. One ﬁgure published under a
Creative Commons Attribution license has been reproduced in the background section
(Figure 3.2.b).

vi

TABLE OF CONTENTS
Page
LIST OF TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

x

LIST OF FIGURES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xi
ABBREVIATIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xviii
ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xx
1 INTRODUCTION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

1

2 MOTIVATION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

2

3 BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

3

3.1

Human Abdominal Aortic Aneurysms . . . . . . . . . . . . . . . . . . .

3

3.1.1

Atherosclerosis and AAAs . . . . . . . . . . . . . . . . . . . . .

4

3.1.2

Vascular Imaging . . . . . . . . . . . . . . . . . . . . . . . . . .

5

3.2

Experimental angiotensin II-induced model of dissecting AAAs . . . . .

6

3.3

Critical gap in the literature . . . . . . . . . . . . . . . . . . . . . . . .

9

3.4

Opportunities for research with the angiotensin II model . . . . . . . . 10

3.5

3.4.1

Similarities to human AAA . . . . . . . . . . . . . . . . . . . . 11

3.4.2

Issues with the disease model . . . . . . . . . . . . . . . . . . . 12

Site-speciﬁc formation of AAAs . . . . . . . . . . . . . . . . . . . . . . 13

4 COMPARISON OF AORTIC DISEASE MODELS . . . . . . . . . . . . . . 15
4.1

Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15

4.2

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16

4.3

Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
4.3.1

Animal care and maintenance . . . . . . . . . . . . . . . . . . . 17

4.3.2

Elastase perfusion surgery in rats . . . . . . . . . . . . . . . . . 18

4.3.3

Implantations of angiotensin II-loaded miniosmotic pumps in
mice . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18

vii
Page
4.3.4

Small animal ultrasound imaging . . . . . . . . . . . . . . . . . 19

4.3.5

Blood pressure measurements . . . . . . . . . . . . . . . . . . . 20

4.3.6

Ultrasound analysis . . . . . . . . . . . . . . . . . . . . . . . . . 20

4.3.7

Animal perfusion and dissection . . . . . . . . . . . . . . . . . . 22

4.3.8

Aortic tissue histology and staining . . . . . . . . . . . . . . . . 22

4.3.9

Nonlinear optical microscopy . . . . . . . . . . . . . . . . . . . . 22

4.3.10 Image processing and semiquantitative analysis . . . . . . . . . 23
4.3.11 Statistical analysis . . . . . . . . . . . . . . . . . . . . . . . . . 23
4.4

Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24
4.4.1

Small animal ultrasonography of AAAs enables longitudinal
monitoring of aortic diameter expansion and volume growth
over time . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24

4.4.2

Circumferential cyclic strain rapidly decreases in AAAs . . . . . 25

4.4.3

Mean blood ﬂow velocity decreases in both AAA models and
recirculates in suprarenal AAAs . . . . . . . . . . . . . . . . . . 26

4.4.4

AAAs exhibit elastin degradation and collagen deposition by
histological staining . . . . . . . . . . . . . . . . . . . . . . . . . 26

4.4.5

Nonlinear optical microscopy enables label-free imaging of elastin
and collagen in ex vivo AAA tissue . . . . . . . . . . . . . . . . 27

4.5

Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28

4.6

Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32

5 VARIABILITY IN THE MORPHOLOGY AND HEMODYNAMICS OF
DISSECTING ABDOMINAL AORTIC ANEURYSMS . . . . . . . . . . . . 39
5.1

Abstract . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39

5.2

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 40

5.3

Materials and Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . 41
5.3.1

Animal study . . . . . . . . . . . . . . . . . . . . . . . . . . . . 41

5.3.2

Mini-osmotic pump implantations . . . . . . . . . . . . . . . . . 41

5.3.3

Ultrasound . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42

5.3.4

Blood pressure measurements . . . . . . . . . . . . . . . . . . . 44

viii
Page

5.4

5.5

5.3.5

Ultrasound analysis . . . . . . . . . . . . . . . . . . . . . . . . . 44

5.3.6

Optical coherence tomography (OCT) and co-registration with
ultrasound data . . . . . . . . . . . . . . . . . . . . . . . . . . . 45

5.3.7

Computational ﬂuid dynamics modeling . . . . . . . . . . . . . 47

5.3.8

Aortic tissue histology and analysis . . . . . . . . . . . . . . . . 48

Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49
5.4.1

Dissection results in rapid changes in geometry . . . . . . . . . 49

5.4.2

Dissections increase aortic stiﬀness and alter hemodynamics
leading to acute but evolving thrombus . . . . . . . . . . . . . . 50

5.4.3

Multi-modality reconstructions compare well with histology

5.4.4

Advantages of 3D US-OCT . . . . . . . . . . . . . . . . . . . . 51

5.4.5

Hemodynamic simulations agree well with measurements . . . . 52

5.4.6

3D US-OCT based simulations of false lumen ﬂow . . . . . . . . 53

. . 51

Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55

6 QUANTITATIVE CHARACTERIZATION OF SUSCEPTIBILITY TO
DISSECTING AAA FORMATION . . . . . . . . . . . . . . . . . . . . . . . 72
6.1

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 72

6.2

Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 75

6.3

6.2.1

Experimental design . . . . . . . . . . . . . . . . . . . . . . . . 75

6.2.2

In vivo ultrasound imaging and blood pressure collection . . . . 75

6.2.3

Animal sacriﬁce and tissue collection . . . . . . . . . . . . . . . 76

6.2.4

Histology and immunohistochemistry . . . . . . . . . . . . . . . 76

6.2.5

Total RNA extraction, dilution and pooling . . . . . . . . . . . 77

6.2.6

cDNA library construction, puriﬁcation and quantiﬁcation . . . 77

6.2.7

mRNA sequencing and bioinformatics . . . . . . . . . . . . . . . 78

6.2.8

Real-time PCR and relative gene expression analysis . . . . . . 78

Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79
6.3.1

Angiotensin II infusion leads to abrupt dissecting AAA
formation over a range of diagnosis days . . . . . . . . . . . . . 79

ix
Page

6.4

6.5

6.3.2

Angiotensin II infusion leads to volumetric growth and strain
reduction regardless of dissecting AAA status . . . . . . . . . . 80

6.3.3

Inﬂammation- and extracellular matrix-related genes are
diﬀerentially expressed among experimental cohorts . . . . . . . 81

6.3.4

A subset of diﬀerentially expressed genes related to
inﬂammation and extracellular matrix remodeling shows
diﬀerential expression in the suprarenal aorta . . . . . . . . . . 83

6.3.5

Suprarenal aorta Il1b expression is associated with aortic size
and strain . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 84

6.3.6

Regulation of neutrophil migration, neutrophil chemotaxis,
monocyte chemotaxis, blood coagulation, and cellular
extravasation are enriched in dissecting AAAs . . . . . . . . . . 84

6.3.7

Comparative analysis of diﬀerentially expressed genes after acute
and chronic angiotensin II infusion . . . . . . . . . . . . . . . . 85

6.3.8

Early dissecting AAA histology and immunohistochemistry . . . 86

Discussion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 86
6.4.1

Aortic expansion and vessel wall pulsatility in the AngII No
AAA cohort . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87

6.4.2

Aortic gene expression of matrix remodeling enzymes and
extracellular matrix proteins . . . . . . . . . . . . . . . . . . . . 88

6.4.3

Inﬂammatory gene expression signatures . . . . . . . . . . . . . 90

6.4.4

Potential disease regulator biomarkers and therapeutic targets . 92

Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 93

7 SYNTHESIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 105
7.1

Overview of research ﬁndings . . . . . . . . . . . . . . . . . . . . . . 105

7.2

Directions for future research . . . . . . . . . . . . . . . . . . . . . . 105

7.3

Translational signiﬁcance . . . . . . . . . . . . . . . . . . . . . . . . . 106

REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
VITA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 128

x

LIST OF TABLES
Table

Page

4.1

Summary of values measured at days 0 and 28 in low- and high-concentrationelastase rats and AngII apoE −/− mice . . . . . . . . . . . . . . . . . . . . 38

5.1

Comparison of length and volume measurements obtained using 3D US
images alone versus enriched 3D US+OCT images . . . . . . . . . . . . . . 69

5.2

Inlet and outlet boundary conditions used in the ﬂuid dynamic simulations 70

5.3

Characteristic features of the four lesions studied (M1 to M4), ordered
based on the size of the false lumen at day 7 following the onset of the
dissection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 71

6.1

SBP rises modestly within 10 days after implantation of AngII-ﬁlled pumps.
Animal-speciﬁc SBP values are shown at baseline (prior to pump implantation) and at a time point post-implantation. Each value is an average
from at least 11 valid runs with measured ﬂow of more than 4 µL/min.
The average percent increase in SBP was similar for the AngII AAA and
AngII No AAA cohorts (20 and 26%, respectively) and the increases were
statistically signiﬁcant. The percent change in SBP was minimal for the
two animals measured in the Saline cohort. . . . . . . . . . . . . . . . . . 102

6.2

Top 30 up-regulated genes with associated log2 fold change for AngII AAA
vs. AngII No AAA comparison . . . . . . . . . . . . . . . . . . . . . . . 103

6.3

Top 30 down-regulated genes with associated log2 fold change for AngII
AAA vs. AngII No AAA comparison . . . . . . . . . . . . . . . . . . . . 104

xi

LIST OF FIGURES
Figure
3.1

3.2

Page

Short-axis US image of an AAA with a thrombus encircling the inside of
the aortic wall (”Aorta Ultrasound - Aneurysms - SonoSite, Inc.”
www.youtube.com/watch?v=WKnFD6KeO4c) . . . . . . . . . . . . . . . .

6

Schematics of two mechanisms of activation of IL-1β through (a) inﬂammasome sensing of a danger signal from outside of the cell and (b)
inﬂammasome-independent protease cleavage. TLR: Toll-like receptor.
PR3: proteinase-3. Panel A is adapted from an online image by Arigo
Biolaboratories, www.arigobio.com. Panel B is adapted from a ﬁgure published in [78]. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

8

3.3

Gross appearance of a murine suprarenal aorta with a dissecting AAA
(left) as compared to the infrarenal aorta (right). . . . . . . . . . . . . . . 11

4.1

Circumferential cyclic strain decreases over 28 days. Representative longaxis M-mode tracings (days 0 and 28) and longitudinal measurements of
circumferential cyclic strain at site of AAA for high-concentration-elastase
rats (a) and AngII apoE −/− mice (b). Inset in (b): longitudinal measurements of systolic and diastolic blood pressure in AngII apoE −/− mice. . . . 33

4.2

Circumferential cyclic strain decreases over 28 days. Representative longaxis M-mode tracings (days 0 and 28) and longitudinal measurements of
circumferential cyclic strain at site of AAA for high-concentration-elastase
rats (a) and AngII apoE −/− mice (b). Inset in (b): longitudinal measurements of systolic and diastolic blood pressure in AngII apoE −/− mice. . . . 34

4.3

Mean aortic blood ﬂow velocity decreases after 28 days. Representative
velocity waveforms on long-axis PW Doppler acquisitions (days 0 and 28)
and corresponding measurements of mean blood ﬂow velocities at site of
AAA in high-concentration-elastase rats (a) and AngII apoE −/− mice (b).

4.4

35

Gross dissection of AAAs shows shape of AAAs detected by B-mode images. End-of-study dissection images of AAAs in situ and short-axis Bmode images at day 28 from a high-concentration-elastase rat ((a), (c))
and an AngII apoE −/− mouse ((b), (d)). B-mode images taken at the
approximate anatomical locations marked by green dashed lines ((a) and
(b)). White dashed lines indicate locations selected for histology. Scale
bars: 5 mm (a); 2 mm (b); 2 mm (c); and 1 mm (d). . . . . . . . . . . . . 35

xii
Figure

Page

4.5

Histological staining reveals qualitative and semiquantitative diﬀerences in
elastin and collagen content of AAAs. Representative MTC ((a), (b)) and
VVG ((c), (d)) images of AAA tissue from a high concentration elastase
rat ((a), (c)) and an AngII apoE −/− mouse ((b), (d)). Normalized measurements of mean elastin and collagen content ((e), (f)) in high- (n=5)
and low- (n=4) concentration-elastase rats (e) and AngII apoE −/− mice
(n= 6) (f). Controls (n=3 in each group) are sections with healthy regions.
Scale bars: 200 µm at low and 100 µm at high magniﬁcation. Level of
magniﬁcation: 8x ((a), (c)) and 2x ((b), (d)) relative to low magniﬁcation. 36

4.6

Nonlinear optical microscopy provides a label-free approach for examination of AAA tissue morphology and protein content. SHG (green), TPEF
(red), and merged SHG/TPEF nonlinear optical images of representative
aortic tissue sections from healthy and AAA regions in low- and highconcentration-elastase rats (a), and AngII apoE −/− mice (b). Scale bars:
100 µm. Black arrows point to adventitial collagen; white arrows point to
degraded elastin bands; and asterisks indicate agarose gel in lumen. . . . . 37

5.1

Combined 3D US-OCT imaging technique. By co-registering ﬁducial markers at easily recognizable locations (e.g., branch ostia), we obtained highresolution merged datasets that provided morphologic detail suﬃcient to
delineate diﬀerent regions of vasculature in and near the dissection. Left
and middle images show illustrative sections. A reconstructed vessel with
a suprarenal dissecting abdominal aortic aneurysm (red), including an enclosed false lumen (FL) and intramural thrombus (T) is shown on the
right (blue). res = resolution; US = ultrasound; OCT = optical coherence
tomography. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 59

5.2

One-dimensional (1D) surrogate model of wave propagation. This 1D
model for mouse M3 (right) was built by extracting centerlines from the
reconstructed 3D geometric model (left). The solution of the 1D wave
propagation via a spectral ﬁnite element method was used in a derivativefree optimization scheme to compute optimal outlet capacitance values
to match measured velocity waveforms at the outlets. PA = proximal
abdominal aorta; CA = celiac artery; FL = false lumen of the dissection;
SMA = superior mesenteric artery; RRA and LRA = right and left renal
artery; IA = infrarenal abdominal aorta; Cx = capacitance for vessel x. . . 60

xiii
Figure

Page

5.3

Aortic volumes before dissection and during ﬁrst week after diagnosis. (a)
Representative segmentation results of 3D US images for mouse M3. (b)
Average changes in volume across diﬀerent regions within each of the four
lesions (M1 to M4). (c) Volume changes over time for all four mice studied
(M1 to M4). Total volume of the lesion includes true lumen, false lumen,
and thrombus; volume for the dissected region includes false lumen and
thrombus. A thickened vessel wall without thrombus is present in M1.
NA = no measurement made due to interference from bowel gas in US
images (see image of M4 in Figure 5.9) . . . . . . . . . . . . . . . . . . . . 61

5.4

Maximum AAA expansion over time. (a) Axial B-mode images of M3 at
baseline, day 0, and day 7. Maximum cross-sectional area was measured
to estimate the change in eﬀective maximum diameter of the suprarenal
aorta. 1 mm scale. (b) Time-varying changes in eﬀective maximum diameter (EMD). (c) The relationships between EMD and total AAA volume/length as well as EMD and thrombus volume/length are shown at
days 0, 1, 3, 5, and 7 relative to the ﬁrst observation of dissection / disease.
In panels (b) and (c), average values ± standard error are shown for M2,
M3, and M4. For panel (c), total AAA and thrombus measurements have
R2 values of 0.89 and 0.53, respectively. V = ventral; L = left. . . . . . . . 62

5.5

Evolution of average velocity and wall displacement waveforms as assessed
by US measurements before and during the ﬁrst week after diagnosis. (a)
True lumen centerline velocity waveforms were averaged over 20 or more
cardiac cycles. Measurements were acquired just proximal to the location
of the oriﬁce of the dissection at baseline (day -1), at diagnosis (day 0),
and one week after diagnosis (day 7). (b) Evolution of mean velocity
at the same location for all mice during the ﬁrst week of development.
(c) Wall displacement waveforms measured near the point of maximal
aortic diameter prior to and after (days 0 and 7) dissection. (d) Evolution
of the cyclic circumferential Green strain at the same location for the
dissected aneurysmal wall during the ﬁrst week of development. NA = no
measurement made due to interference from bowel gas in US images. . . . 63

xiv
Figure

Page

5.6

3D Solid models reconstructed with our multi-modality technique and
compared at key cross-sections. Co-registered 3D US (grey), OCT (red)
datasets, and histological sections (Movat stain) taken at approximately
the same location are shown. Note that thrombus stains red in Movat,
elastin black, and collagen brown-grey. cc - coronal section; ax1- proximal axial cross-section; ax2 middle axial cross-section, ax3 distal axial
cross-section, ax representative axial cross-section for M1, which exhibited little axial variation. Note that the cannula used in the OCT studies
is visualized in part in the cross-sectional views (inner red circle). White
scale bar = 1 mm; black scale bar = 500 µm. Recall Figure 5.1 where
OCT and US images are shown separately for the same sections. . . . . . . 64

5.7

Bland-Altman plot showing relative diﬀerences between volume measurements obtained with US and US+OCT techniques for diﬀerent regions.
The values 0.5(VU S + VU S+OCT ) on the x-axis are normalized so that the
mean for each region equals 1. Note the large discrepancies in relative
diﬀerences of the false lumen volumes, for which the US+OCT technique
can likely resolve the morphology at higher detail. . . . . . . . . . . . . . . 65

5.8

Volume rendering and mean velocity waveforms for computational simulations for mice M1 to M4. Color-coded simulations display the velocity
magnitude at systole (left) and diastole (right). Simulated velocity waveforms (solid lines) are also compared to ultrasound measurements (dashed
lines) at all major inlets and outlets as well as at an intermediate proximal
location used to validate, and not inform, the model. . . . . . . . . . . . . 66

5.9

Comparison of hemodynamic simulations with EKV snapshots for mice M1
to M4. Color-coded λ2 distributions in lateral cross-sections (left) show
evolving vortical structures throughout a cardiac cycle. Overlapped in red
are selected streamlines (tangents to computed velocities). EKV snapshots
(right) are overlapped to representative trajectories tracked using a digital
image correlation algorithm. The white asterisk denotes a region of bowel
gas obstruction. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67

5.10 Average systolic, diastolic, and mean arterial blood pressures (n=4) before
and after pump implantation. Systolic pressure rose to 169±26 mmHg at
day 12 post-surgery (i.e., day 4 on average post-diagnosis) from 117±34
mmHg before implantation (p =0.05). . . . . . . . . . . . . . . . . . . . . . 68

xv
Figure

Page

6.1

Experimental design for in vivo monitoring and sacriﬁces of cohorts. Twelve
animals were assigned to either cohorts 1 (AngII AAA) and 2 (AngII No
AAA) depending on whether a dissecting AAA was identiﬁed by day 10
after AngII pump implantation. Three additional animals were monitored
but excluded from the study. Two of these animals were moribund and
one experienced an aortic rupture before ﬁnal full US datasets were collected. Five animals in cohort 3 (Saline) were implanted with saline-ﬁlled
pumps. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 95

6.2

Example B-mode (left) and M-mode (right) images at baseline, an intermediate screening day, and endpoints for each cohort . . . . . . . . . . . . 96

6.3

Volumetric growth and reduction in vessel wall strain occur with AngII infusion regardless of dissecting AAA status. a) Volume/length diﬀerences
across AngII AAA, AngII No AAA and Saline cohorts. 2-way ANOVA
with Sidak multiple comparisons. Open circles: baseline; Black circles:
endpoint. b) 3D B-mode data for an AngII AAA mouse. V: ventral;
Cr: cranial c) Suprarenal aorta renderings show complex morphology in
a leftward-expanding lesion for AngII AAA, moderate vessel expansion
for AngII No AAA, and a healthy vessel for Saline cohorts. d) Example
time-averaged inner diameter measurements (± standard deviation) over
a cardiac cycle. Diﬀerences between peak systolic (Ds ) and end diastolic
(Dd ) inner diameter are shown. e) EMD at the animal-speciﬁc endpoint.
1-way ANOVA with Tukey multiple comparisons. f) CCS at the animalspeciﬁc endpoint. 1-way ANOVA with Tukey multiple comparisons. g)
Correlation between vessel strain and aortic diameter. CCS is plotted
against corresponding EMD (triangles: Saline cohort; squares: AngII No
AAA cohort; circles: AngII AAA cohort). Linear regression (solid line)
and 95% conﬁdence interval (dashed lines) are shown. Slope: -13.11. Correlation coeﬃcient (r): -0.82. p=0.0001. *p<0.05; **p<0.001 . . . . . . . 97

xvi
Figure

Page

6.4

a) 346 signiﬁcant diﬀerentially expressed genes (DEGs) selected (fold change
greater than 1.5 and adjusted p-value less than 0.1). Number of unique
DEGs (dashed line circles) is largest for highest expected contrast and
smallest for lowest expected contrast. b) Heat map and dendrogram of
DEGs across comparisons. Raw z-scores are color-coded. Scale bar: upregulated (red), downregulated (green) and no change (black). c) Realtime PCR validation of selected DEGs (mir223, Eln, Col4a3, Mmp9, and
Il1b). Ppia was ﬁrst validated and used as a housekeeping gene for each
run. Each assay was run in duplicate and 3 to 5 biological replicates
per cohort were used. One-way ANOVA with Holm-Sidak multiple comparisons of each cohort (*p<0.05; **p<0.001). d, e) Linear regression
analysis between diameter, strain and gene expression of Mmp9 and Il1b
across three cohorts. EMD (mm) and CCS (%) are plotted against corresponding ΔCT values (housekeeping gene-corrected cycle threshold values
for a target gene) for (a) Mmp9 and (b) Il1b. Note that higher ΔCT values
represent longer ampliﬁcation and lower relative expression. Correlation
coeﬃcients (r): -0.89 (Mmp9 vs. EMD); 0.86 (Mmp9 vs. CCS); -0.94
(Il1b vs. EMD); 0.87 (Il1b vs. CCS). Solid symbols: EMD; Open symbols: CCS; Circles: AngII AAA cohort; Squares: AngII No AAA cohort;
Triangles: Saline cohort. Two data points from the AngII AAA cohort
were excluded as outliers. . . . . . . . . . . . . . . . . . . . . . . . . . . . 98

6.5

Enriched gene ontology (GO) terms for biological processes (adjusted
p<0.05 using weight pruning correction) identiﬁed using Advaita Bio’s
iPathwayGuide. Examples of enriched biological processes are shown. . . . 99

6.6

Movat’s Pentachrome (MOV) staining of a dissecting AAA shows focal
breakage of elastin (arrow) and evidence of cell inﬁltration. Adventitial
collagen staining (yellow/green; arrowhead) appears more abundant in
the infrarenal aorta. Martius, Scarlet and Blue (MSB) staining of the
same tissue shows an intramural thrombus (asterisk) by positive ﬁbrin
(red) and red blood (yellow) stains in proximity to the focal dissection.
Adventitial collagen staining (blue; arrowhead) appears more abundant in
the infrarenal aorta. Scale bars: 500, 200, and 50 µm for low, middle, and
high magniﬁcation, respectively. . . . . . . . . . . . . . . . . . . . . . . 100

xvii
6.7

3,3’diaminobenzidine IHC of MMP-9 (a), IL-1β (b), Ly6G+ neutrophils
(c), and F4/80+ macrophages (d) of a dissecting AAA (each left image)
and the accompanying non-dissected infrarenal aorta (each right image).
MMP-9 is co-distributed with neutrophils and macrophages in the adventitia. In the dissected region (hypocellular region at the bottom of each
left image), neutrophils are abundant and MMP-9 and IL-1β are observed
along the interface with the elastic lamina (black arrows). The infrarenal
aorta shows little positive staining in the vessel wall. Scale bars: 200 µm. 101

xviii

ABBREVIATIONS
AAA

abdominal aortic aneurysm

AngII

angiotensin II

apoE

apolipoprotein E

CA

celiac artery

CCS

circumferential cyclic strain

CFD

computational ﬂuid dynamics

CT

computed tomography

EC

endothelial cell

EKV

ECG-gated Kilohertz Visualization

EMD

eﬀective maximum diameter

FL

false lumen

H&E

hematoxylin and eosin

IL-1β

interleukin 1-beta

ILT

intraluminal thrombus

IRA

infrarenal aorta

LRA

left renal artery

MCP-1

Monocyte chemoattractant protein-1 / C-C Motif Chemokine
Ligand 2

MMP

matrix metalloproteinase

MOV

Movat’s pentachrome

MRI

magnetic resonance imaging

MSB

Martius, Scarlet, and Blue

MTC

Masson’s Trichrome

NLO

nonlinear optical

xix
NLRP3 NLR Family Pyrin Domain Containing 3
OCT

optical coherence tomography

PR3

proteinase-3

RRA

right renal artery

SAA

suprarenal abdominal aorta

SBP

systolic blood pressure

SMA

superior mesenteric artery

SRA

suprarenal aorta

TL

true lumen

TLR

Toll-like receptor

US

ultrasound

VSMC

vascular smooth cell muscle

VVG

Verhoeﬀ Van-Gieson

xx

ABSTRACT
Phillips, Evan H. Ph.D., Purdue University, August 2018. Imaging and Molecular
Analysis of Murine Dissecting Abdominal Aortic Aneurysms.
Major Professor:
Craig J. Goergen, Assistant Professor.
An abdominal aortic aneurysm (AAA) is a localized expansion of the aorta. This
disease can sometimes be caused by aortic dissections where the layers of the vessel
wall separate, creating a false channel for blood to ﬂow. AAAs are life-threatening
because weakening of the vessel wall can lead to aortic rupture and internal bleeding.
Unfortunately, most AAAs are associated with no signs or symptoms. Early diagnosis
is therefore often not possible and recommendation for life-saving surgery could be
delayed. As a result, the mortality rate for patients who experience aortic rupture
is up to 90%. Currently we have an incomplete understanding of disease progression
because aortic tissue is explanted only at a late stage of the disease. Hemodynamics
and biomechanical forces on the vessel wall are thought to be important in development. These factors require further investigation with speciﬁc focus on the ongoing
extracellular matrix remodeling and inﬂammatory processes.
The overall goal of this work is to characterize the development of an established
murine dissecting AAA model by integrating in vivo ultrasound with ex vivo molecular analyses. The novelty of this work is the longitudinal assessment of this model
from early to late development and the utilization of advanced small animal imaging
to identify pathology in vivo. Complex blood ﬂow and vessel wall thrombus develop
early and abruptly, likely inﬂuencing vascular growth and remodeling. In diseased
animals, we measured signiﬁcant volumetric growth of the suprarenal aorta, reﬂecting the large asymmetric expansion that is typically seen with this model. As well,
a reduction in circumferential cyclic strain occurred in the suprarenal aortic wall,

xxi
indicating that the vessel wall became regionally stiﬀer. By histology, we observed
characteristic features of the model, such as focal elastin breakage in the medial layer
and collagen breakdown and remodeling in the adventitial layer. We also identiﬁed
gene expression signatures for the early pathology that occurs in this model, including
proinﬂammatory processes involving macrophages and neutrophils as well as vessel
wall remodeling involving matrix metalloproteinases. The morphological, biomechanical, and hemodynamic changes in dissecting AAAs reﬂect both the microstructural
changes and gene expression proﬁle identiﬁed.
Advanced ultrasound imaging to measure vessel strain and volume could help
improve our prediction capabilities by identifying patients who are at greater risk
for expansion and rupture. Additionally, a subset of identiﬁed biomarkers could
serve as potential diagnostic or therapeutic targets that warrant further evaluation.
Ultimately, we aim to help develop a means for accurate early diagnosis and treatment
of human aortic disease.
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1. INTRODUCTION
An abdominal aortic aneurysm (AAA) is a localized expansion of the aorta. This
disease can sometimes be caused by aortic dissections where the layers of the vessel
wall separate, creating a false channel for blood to ﬂow. AAAs are life-threatening
because weakening of the vessel wall may lead to aortic rupture and internal bleeding.
Making matters worse, many people that have an AAA do not know they have one.
AAAs are often associated with no overt signs or symptoms. As a result, early
diagnosis is often not possible and if a recommendation for life-saving surgery were
to be made, it could be delayed.
We currently have an incomplete understanding of AAA development because
aortic tissue is explanted only at a late stage of the disease. Computed tomography
and ultrasound imaging are invaluable tools that allow for noninvasive monitoring of
aortic size and expansion rate. Imaging-derived data can also provide information
about blood ﬂow dynamics and biomechanical properties of the aortic vessel wall.
These are important factors that show a relationship to disease development. Biological processes mediate systemic and local vascular disease and may be inﬂuenced by
physical forces acting upon the vessel wall.
The purpose of this dissertation research is to characterize the vascular growth
and remodeling in an established model of murine dissecting AAAs at multiple time
points. Both the limited understanding of how this model develops in vivo and how
disease development is initiated motivated the studies conducted. The high-resolution
capabilities of in vivo small animal ultrasound are used consistently to longitudinally
track and screen animals during development.
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2. MOTIVATION
The ultimate goal in aortic disease research is to prevent aortic rupture and decrease
high mortality in patients. As a whole, this dissertation research is motivated by this
clinical need. The studies conducted stem from three avenues of research that are
being pursued in vascular or biomedical research.
The ﬁrst avenue is the identiﬁcation and implementation of molecular or imaging
biomarkers that can be tracked in diagnosed patients. Aortic diameter is the gold
standard measurement in AAA patients. Many researchers are exploring whether
more advanced imaging-derived measurements and molecular biomarkers are speciﬁc
to aortic disease development. The end goal of such work is to identify biomarkers
that will allow physicians to assess treatment success or to predict the probability of
aortic rupture. Researchers have identiﬁed many potential biomarkers but validation
is diﬃcult.
The second avenue is the identiﬁcation of biomarkers to be used for early screening
of at-risk patients. Such biomarkers could be diagnostic or prognostic and molecular
biomarkers may be suitable for screening prior to imaging. This approach is being
actively pursued in other ﬁelds, such as cancer research.
The third avenue is the development of new treatment options, whether in a molecular, cellular or physical form, that will have an eﬀect on slowing or stopping vessel
expansion. Many research groups are testing diﬀerent strategies using experimental
models. Translation of preclinical ﬁndings however has been slow to date.
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3. BACKGROUND
3.1

Human Abdominal Aortic Aneurysms
The clinical deﬁnition of an AAA speciﬁes that the abdominal aorta has a focal

dilation, typically below the kidneys, of at least 50% above normal, or 3 cm in males
[1–5]. In particular, men over the age of 65 have a higher prevalence of AAAs [6–8]
and patients very often have a history of smoking [1–5]. A 2005 report on practice
guidelines published by The American Heart Association states a prevalence rate
of 12.5% for men and 5.2% for women between 75 and 84 years old. The most
striking statistic, however, is a mortality rate of up to 90% due to aortic rupture [6–8],
making ruptured AAAs ”the 15th leading cause of death overall in the United States”
according to a 2012 report [9]. More recently, according to the Global Burden of
Disease Study in 2013, it is estimated that globally 151,000 men and women died due
to an aortic aneurysm [10].
A maximal aortic diameter of approximately 5.5 cm in men has long been considered an appropriate threshold for AAA surgical repair [11]. Clinical indications of
aneurysm size and expansion rate as well as potential surgical risks will determine if
and when open surgery or a less invasive operation, termed endovascular aneurysm
repair, is appropriate for a patient [11]. AAA patients who have had an aortic rupture
usually experience rapid expansion and present with symptomatic ”back, abdominal
or groin pain” [12]. However, some diagnosed patients experience no progression to
rupture, as the aneurysm remains stable. As such, there is an unmet clinical need
for accurately identifying patients with AAAs who are at risk of rupture. It is also
unclear how predictive the composition of the aortic wall and its surroundings are of
the degree of expansion and the risk of rupture.

4
3.1.1

Atherosclerosis and AAAs

AAA patients often have hypertension or other cardiovascular disease [13–16]. In
fact, atherosclerosis shares common pathogenetic features with AAAs, such that the
disease in some cases appears to initiate from an atherogenic milieu. High levels
of apolipoproteins in the blood [17, 18], for example, are one such common disease
characteristic, albeit not necessarily indicative of coexisting diseases. Importantly,
inﬂammatory cell inﬁltration to the aortic wall is characteristic of both diseases [19–
21], but aortic wall degeneration occurs through diﬀerent mechanisms [9, 21, 22].
Proteolytic degradation of elastin and turnover of collagen ﬁbers in the abdominal aortic wall are hallmarks of AAAs. These changes result in local remodeling and
weakening of the vessel wall [23]. Proteases, such as elastases and collagenases, cause
degradation of elastin in the medial layer and the turnover and loss of interstitial
collagen ﬁbers in the medial and adventitial layers [21, 24–26]. Still, atherosclerosis
and AAAs exhibit elevated levels of various pro-inﬂammatory cytokines [27–30]. Relatively higher levels of T helper cell type 1 cytokines to type 2 cytokines promote
the formation of an occlusive atherosclerotic lesion, while the inverse in these levels
disfavors atherogenesis and favors matrix remodeling [21]. Consequently, one would
expect a spectrum of lesions depending on the activity of these and other factors in
the local microenvironment. Results from the UK Small Aneurysm Trial suggest that
contrary to most researchers understanding atherosclerosis may have no association
or even a negative association with AAA development [31]. Several molecular and
hereditary studies have found evidence for distinct routes of pathogenesis between
AAAs and atherosclerosis [2, 8, 32]. Genetic-based evidence, the existence of familial predisposition, and the identiﬁcation of local inﬂammatory eﬀects reinforce that
AAAs are not simply a consequence of other cardiovascular disease.
Considering these ﬁndings together, it is clear that atherosclerosis and AAAs have
general similarities in precursor events, but it has been challenging to diﬀerentiate
the underlying pathogenetic mechanisms. We require a better understanding of early
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AAA development in order to identify diagnostic or therapeutic markers. To undertake this problem, noninvasive imaging is an essential tool.

3.1.2

Vascular Imaging

Diﬀerent imaging modalities enable clinicians to identify and monitor AAAs.
Computed tomography (CT) and magnetic resonance imaging (MRI) with or without
contrast medium or ultrasound (US) will be selected depending on cost, utility in a
particular case, and the patients weight [9]. While CT and MRI provide high spatial resolution and diagnostic accuracy, US may be preferable in cases where factors
such as availability, cost, and radiation exposure are of primary concern. As an AAA
may be asymptomatic until a rupture occurs, the initial diagnosis of a non-ruptured
AAA is often an incidental ﬁnding. Diﬀerences in AAA expansion rates lead one to
consider how frequently patients should be screened and monitored by US or CT and
how timely recommendations for surgery can be made in current practice.
US and CT are established in the clinic and essential for determining aortic diameter and anatomy of adjacent structures in AAA patients (Figure 3.1). However, other
imaging-based approaches are being used to detect and quantify relevant factors,
such as wall stress [33], aortic blood ﬂow [34], and inﬂammation [35, 36]. Localized
stresses that cannot be withstood by the vessel wall are ultimately responsible for
ruptures [23, 33]. These approaches are being applied in human [37] and preclinical [38, 39] studies. The human studies can provide longitudinally acquired images
for research to predict aortic rupture potential and to assess the diagnostic value of
these methods. Preclinical research is meanwhile employing anatomical, functional,
and molecular imaging approaches to study AAA therapies and progression patterns
in animal models [38]. The need for such research seems clear, considering the multifactorial nature of the disease and the range of potential biomarkers.
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Fig. 3.1.: Short-axis US image of an AAA with a thrombus encircling the inside of
the aortic wall (”Aorta Ultrasound - Aneurysms - SonoSite, Inc.”
www.youtube.com/watch?v=WKnFD6KeO4c)

3.2

Experimental angiotensin II-induced model of dissecting AAAs
Experimental animal models have been established over the last 25 years to in-

vestigate AAA pathology [40–42]. These models can recapitulate aspects of the
human disease [43, 44] and there have been multiple research eﬀorts investigating
diﬀerent disease factors. Mechanistic studies have revealed potential developmental
pathways [45–50] and therapeutic targets [51–55] for AAAs in humans. Speciﬁc therapeutic targets and diagnostic biomarkers [56, 57] are therefore highly desired [58].
In 2000, Daugherty et al. ﬁrst observed suprarenal aortic expansion due to continuous infusion of angiotensin II (AngII) in apolipoprotein E-deﬁcient (apoE −/− )
mice [41]. They found a higher rate of AAA incidence in these atherosclerosis-prone
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mice, particularly males of advanced age, as compared to wildtypes [41, 59]. AngII,
which is known to enhance atherogenesis [60, 61], is a key stimulus for formation
of these AAAs [59, 62]. The most salient feature of this model is an aortic dissection, resulting in leftward expansion of the aorta [63] proximal to the right renal
artery [64, 65]. The aortic dissection creates a false lumen within the vessel wall [66]
and separates the medial and adventitial layers of the suprarenal aorta [64]. Blood
entering the false lumen recirculates [67,68] and clots leading to formation of intramural thrombus [64]. A focal aortic dissection, a false lumen, and intramural thrombus
are therefore distinguishing features of this model. Extensive work over the past 15
years has revealed the complex morphology and composition of lesions in this model,
primarily using standard histology [64, 69] or immunohistochemistry [47, 70].
Many research eﬀorts have investigated the pro-inﬂammatory environment in both
human [58, 71] and murine [72, 73] AAAs. Tieu et al. previously found that older
wildtype mice infused with high doses of AngII had early aortic dissections, which
were ablated when using IL-6 knockout mice [72]. This and other work elegantly show
that with AngII infusion in non-hyperlipidemic mice, aortic adventitial ﬁbroblasts in
the suprarenal aorta trigger an ampliﬁcation loop of IL-6 and monocyte chemoattractant protein-1 (MCP-1), inducing monocyte recruitment and inﬂammation and
promoting extracellular matrix degradation and aortic dissections [70,72]. Usui et al.
have also provided strong evidence that AngII infusion in hyperlipidemic apoE −/−
mice leads to activation of the NLRP3 inﬂammasome [46]. The NLRP3 inﬂammasome [74–76] is a complex of cytosolic proteins that regulates the production of a proinﬂammatory cytokine IL-1β (Figure 3.2), which can in turn induce IL-6 [77]. Their
work suggested that an endogenously activated NLRP3 inﬂammasome in adventitial
macrophages could be involved in this induction cascade upstream of vascular inﬂammation and extracellular matrix remodeling in AngII-induced AAAs [46]. Therefore,
the pro-inﬂammatory genes, which are up-regulated during inﬂammatory cell recruitment and vascular remodeling, are important in revealing the progression of AAA
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development. Furthermore, small animal imaging allows for noninvasive assessment
of disease processes in vivo.

Fig. 3.2.: Schematics of two mechanisms of activation of IL-1β through (a) inﬂammasome sensing of a danger signal from outside of the cell and (b) inﬂammasomeindependent protease cleavage. TLR: Toll-like receptor. PR3: proteinase-3. Panel A
is adapted from an online image by Arigo Biolaboratories, www.arigobio.com. Panel
B is adapted from a ﬁgure published in [78].

Small animal imaging is a powerful yet largely underutilized tool. Advanced imaging technology opens opportunities for developing diagnostic and prognostic indicators
for AAAs and accelerating the translation of preclinical ﬁndings [79]. The primary
advantages are twofold. First, tracking disease progression or treatment response
over time provides dynamic subject-speciﬁc information and reduces the total number of study animals required. Second, the appropriately chosen imaging technique
can provide real-time measurements of in vivo properties, such as vessel length or
aneurysm diameter. Some groups have used US and MRI to assess morphological
changes, such as aortic diameter [80–83], and biomechanical changes, such as vessel
pulsatility [63, 84, 85]. Goergen et al. showed that maximal reductions in circumferential cyclic strain and increases in aortic diameter coincided in the day 7 to 14
window after the start of AngII infusion [63]. Furthermore, blood ﬂow dynamics in the
suprarenal aorta are aﬀected during AAA development [67,86]. Areas of recirculating
and lower velocity ﬂow are notable adjacent to focal dissections [67].
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The studies I have conducted build on the concepts of dissecting AAA development
in the apoE −/− animal model with AngII infusion. I propose that changes in AAA
volume, circumferential cyclic strain, and blood ﬂow dynamics are critical assessment
parameters during lesion development. For this reason, noninvasive screening by US
for the ﬁrst sign of aortic disease development is valuable for future experimental
studies.

3.3

Critical gap in the literature
In critically analyzing the research to date in human AAAs, I ﬁnd that there is

a gap in our ability to study early disease development and an unmet need to more
sensitively and dynamically track progression. A major limitation of using surgical
biopsies as research specimens is that they are explanted at a late stage of disease [87].
Using CT or US images, measurements of the maximum transverse aortic diameter
are used to determine AAA size. Diameter alone however is not always predictive of
an aortic rupture due to failure of the vessel wall [9, 33, 88, 89] and the accuracy of
diameter measurements by US is user-dependent. Advanced imaging in combination
with blood biomarker analysis could be a sensitive approach for early disease detection
and therapeutic targeting. Drugs, such as doxycycline, which have entered clinical
trials for AAA patients have suﬀered greatly from inconsistent patient runs and contradictory ﬁndings in limited size patient populations [90]. Investigating experimental
animal models using miniaturized in vivo imaging technology, researchers would be
better poised to test potential therapeutics [91–94] at multiple levels. Currently, no
medical therapies have been proven to prevent aneurysm expansion.
Herein I will introduce how the AngII apoE −/− model provides opportunities to
study AAA development in relation to the human disease. I will also discuss the
relevance of site-speciﬁc formation of AAAs in humans and small animal models and
how a recognized site of formation strengthens the investigation potential of AAAs.
Finally, I will discuss the potential for advanced imaging to characterize parameters
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or components of AAAs. Integrating this technology is beneﬁcial for improving our
understanding of experimental AAAs. It may also have utility for diagnostic and
treatment strategies in AAA patients with a risk of rupture.

3.4

Opportunities for research with the angiotensin II model
Research on the pathogenesis of AAAs has been ongoing since the 1960s. This

work has depended on animal models to mimic a disease state [95,96]. While no single
model recreates the true complexity and heterogeneity of human AAAs or can be
considered the ”perfect” model, well-designed studies permit controlled investigation
of mechanisms and therapeutic eﬀects.
Daugherty and colleagues have established the widely used dissecting AAA model
in mice. In studying the physiological eﬀects of exogenous AngII delivery, they
observed that hyperlipidemic low-density lipoprotein receptor knockout (LDLr −/− )
mice [59] or apoE −/− mice [41] receiving continuous infusion of AngII can develop
suprarenal dissecting AAAs. AngII-infused apoE −/− mice exhibit sudden vessel expansion at a certain time point after the start of AngII infusion from a subcutaneously
implanted miniosmotic pump (Figure 3.3). Saraﬀ et al. meticulously investigated
disease progression in this model and found evidence of medial layer degradation,
macrophage accumulation, inﬂammatory cell recruitment, aortic dissection, thrombus formation, and late-stage plaque build-up [64]. The features of this model relevant
to the human disease include a hyperlipidemic background and inﬂammatory cell recruitment. This enables use of the model in various lines of preclinical investigation,
somewhat diﬀerent than another commonly used AAA model (elastase model [40]).
The foundational papers providing initial characterization of the AngII AAA
model [41, 59, 64] imply that the exact biological and hemodynamic factors linking
a hyperlipidemia genotype to formation of dissecting AAAs are incompletely understood. Other studies have looked directly at the relationship of AAA development
with the apoE −/− model and suggest that hyperlipidemia inﬂuences AAA severity [97]

11

Fig. 3.3.: Gross appearance of a murine suprarenal aorta with a dissecting AAA (left)
as compared to the infrarenal aorta (right).

but is not an absolute prerequisite for formation [49]. Furthermore, AngII dissecting
AAA tissue histology has shown that intraluminal plaques are absent at the point of
aortic dissection [41] but the exact basis or signiﬁcance of this ﬁnding is not clear.
This speaks as well to how we understand AAAs and atherosclerosis in humans. There
is evidence of similar features and mechanisms underlying disease development [98]
but to what extent atherosclerosis is associated with AAAs has remained ambiguous
after years of clinical and preclinical research.

3.4.1

Similarities to human AAA

The progression of AngII-induced dissecting AAA development includes aspects
of human AAAs, particularly inﬂammatory cell recruitment [69], and medial and
adventitial layer remodeling [64]. Changes in the collagen microarchitecture [99, 100]
are ultimately responsible for the possibility of an aortic rupture, but this is an
unpredictable event in this model and can occur in the thoracic aorta. Undoubtedly
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involved in AAA progression is AngII. At the doses delivered, 500 or 1000 ng • min−1 •
kg−1 for up to 28 days, blood pressure increases are typically small [41,59] and AngII
is involved in many other processes, including the activation of inﬂammatory cells
[101] and an increase in oxidative stress [102]. Research by some groups is revealing
the extensive biological eﬀects arising from AngII interaction with inﬂammatory and
vascular cells via its receptors [46, 61, 103].
An important feature of the AngII model that diﬀers from human AAAs is the
presence of an intramural thrombus that results from aortic dissection. Aortic dissections and thrombus within the aortic wall are not typically seen in the human
infrarenal aorta. In human AAAs, however, there is often a thrombus in contact with
the inner wall of the AAA and lumen, an intraluminal thrombus (ILT). Early human
studies showed that ILTs are ﬂuid-ﬁlled networks in contact with the bloodstream
and contain red blood cells, platelets, proteases, and macrophages [104]. Further
in vivo investigation of this seemingly autonomous biological entity would be very
helpful in understanding how it inﬂuences AAA growth and rupture potential. On
account of diﬀerent durations for elastase perfusion and whether rats are used [105],
a thrombus may not develop in the perfused region of the infrarenal aorta using the
elastase model. However, the biological eﬀects of intramural thrombi, which reproducibly form in the AngII model, have not been thoroughly investigated. This key
feature likely inﬂuences vascular growth and remodeling [106].

3.4.2

Issues with the disease model

A recent meta-analysis of 194 publications examined how AngII AAA incidence
and mortality are inﬂuenced by duration of AngII infusion and other factors at the
study and animal level [107]. The key factors responsible for lower AAA incidence
included a wildtype background, low AngII dosage, female sex, and to a lesser extent,
younger animals. From our experience and those of the authors, these factors should
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be controlled for and clearly reported for all animals in order to draw reasonable
conclusions from an experimental study.
One major variable among apoE −/− animals infused with AngII is the occurrence
of initial aortic expansion. The majority of the cited studies employs the time line
for AngII infusion (up to 28 days) as the benchmark for time series analysis of morphological and molecular changes. However, the timing of initial aortic expansion is
clearly variable among animals, typically ranging between 3 and 14 days [63,67]. Not
surprisingly, a short infusion time (less than 7 days) would result in a lower incidence
of AAAs for a typical study [107]. It is by taking advantage of noninvasive imaging
that determining the appearance of an AAA and collecting in vivo measurements are
possible [63, 67, 68, 80, 82, 84, 86, 108, 109].

3.5

Site-speciﬁc formation of AAAs
Among individuals and experimental small animals, AAA development exhibits

temporal and morphological diﬀerences. Furthermore, the site of AAA formation
is typically infrarenal in humans [9], in the perfused infrarenal region of animals
undergoing intraluminal elastase perfusion [40], and proximal to the right renal artery
in the AngII apoE −/− model [63]. The site-speciﬁc formation of AAAs in these three
settings is an essential point to consider.
Patient studies and preclinical research are making use of three interrelated ﬁelds
to understand and study the signiﬁcance of the site of AAA formation: biomechanics [110], biomedical imaging [37], and computational modeling [111]. As one example,
measuring peak wall stress in AAAs by ﬁnite element analysis of human X-ray CT
scans has demonstrated improved prediction accuracy for an aortic rupture as compared to measurement of maximum aortic diameter [33, 112, 113]. Accordingly, the
eﬀect of hemodynamic forces [34,114] and the inﬂuence of aortic shape [115] on the location of AAA formation are critically important. Early clinical studies on unilateral
amputees provide strong evidence for hemodynamic eﬀects inﬂuencing AAA forma-
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tion. Asymmetric blood ﬂow and ﬂow volume strongly aﬀect the risk for infrarenal
AAA development in this population [116, 117].
Macromolecular components of the vessel wall (i.e., elastin and collagen) that resist these forces are implicated in site speciﬁcity of formation. Current biomechanical
and dynamic ﬂow studies are providing more accurate models of AAAs in humans
and small animals by accounting for a number of elements including ILTs [118, 119]
and vessel curvature [120]. The in vivo changes in elastin and collagen during AAA
development are now beginning to be investigated preclinically with the use of novel
targeted molecular imaging probes [66, 121]. However, a well-established means does
not currently exist aside from the use of these contrast agents.
Research on the degeneration and remodeling of extracellular matrix proteins in
the vessel wall has been primarily focused towards elastin and collagen. Biomechanical
testing of human aortic samples [122] conﬁrm that with formation of an AAA, vessel
stiﬀening and decreased vessel distensibility are evident as compared to the healthy
aorta and are associated with elastin degradation. The extent of elastin degradation
and collagen turnover depends partly on the balance of matrix metalloproteinases
(MMPs) and tissue inhibitors of metalloproteinases (TIMPs) [123] active in the vessel wall. Aortic rupture is thought to occur at the point where collagen turnover is
greater than collagen deposition [100] or the cross-linking and ”collagen microarchitecture” are suﬃciently altered [99]. Lindeman and colleagues have disproved the
notion that collagen is defective at the molecular level in AAAs. They have found
stronger evidence that its microarchitecture becomes disorganized, as compared to
healthy braided collagen ﬁbers [99], rendering the aortic adventitia weaker and making the AAA more prone to rupture. The degradation of elastin and turnover and
remodeling of collagen are generally studied as distinct processes. Studying their
temporal changes would be informative to understanding AAA progression and late
stages of the disease relative to the early stages discussed previously.
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4. COMPARISON OF AORTIC DISEASE MODELS
This chapter contains the contents of a published manuscript entitled “ Morphological
and Biomechanical Diﬀerences in the Elastase and AngII apoE −/− Rodent Models of Abdominal Aortic Aneurysms”. I have made edits to the formatting and
wording to match the rest of the dissertation. The published version of this chapter is available under a Creative Commons Attribution License through this link:
http://dx.doi.org/10.1155/2015/413189

4.1

Abstract
An abdominal aortic aneurysm (AAA) is a potentially fatal cardiovascular disease

with multifactorial development and progression. Two preclinical models of the disease (elastase perfusion and angiotensin II infusion in apolipoprotein E-deﬁcient animals) have been developed to study the disease during its initiation and progression.
To date, most studies have used ex vivo methods to examine disease characteristics
such as expanded aortic diameter or analytic methods to look at circulating biomarkers. Herein, we provide evidence from in vivo ultrasound studies of the temporal
changes occurring in biomechanical parameters and macromolecules of the aortic wall
in each model. We present ﬁndings from 28-day studies in elastase-perfused rats and
angiotensin II-infused apolipoprotein E-deﬁcient (apoE −/− ) mice. While each model
develops AAAs speciﬁc to their induction method, they both share characteristics
with human aneurysms, such as marked changes in vessel strain and blood ﬂow velocity. Histology and nonlinear microscopy conﬁrmed that both elastin and collagen,
both important extracellular matrix molecules, are similarly aﬀected in their levels
and spatial distribution. Future studies could make use of the diﬀerences between
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these models in order to investigate mechanisms of disease progression or evaluate
potential AAA treatments.

4.2

Introduction
AAAs are a potentially life-threatening disease, generally deﬁned as a focal dilation

of the aorta to 50% above normal [2]. AAAs accounted for approximately 11,000
deaths in the United States in 2009 and had a prevalence rate of 12.5% for men 75
to 84 years of age in 2006 [124]. The maximum aortic diameter and rate of vessel
expansion in patients are the most important clinical measures in monitoring AAA
progression. However, the unpredictable nature of aortic aneurysm rupture has led
to the active investigation of potential biomarkers and imaging strategies that can be
used to better predict the risk of rupture or improve treatments [57].
Preclinical animal research is important to better understand aneurysm pathophysiology, identify biomarkers, and develop treatment strategies that can be translated to the clinic. Researchers have used two common small animal models in order to investigate AAA disease progression [64, 125] or experimental treatment effects [94, 126, 127]. In one model, pressurized intra-aortic elastase perfusion in the
infrarenal aorta of rats [40, 128] or mice [129] induces mechanical expansion of the
vessel. The perfused region further expands as macrophages inﬁltrate the vessel wall
and matrix proteins in the vessel wall remodel [40,129]. With the second model, subcutaneous systemic infusion of angiotensin II (AngII) in genetically modiﬁed hyperlipidemic mice (apoE −/− ) leads to aortic dissection and expansion of the suprarenal
aorta [41, 64]. Due to these induction mechanisms, there are fundamental diﬀerences
between each model, but they both mimic portions of the human disease [95]. Given
the multifactorial development of AAAs in vivo, studies that rigorously quantify and
monitor progression in multiple disease models are of high value in contributing to
our understanding of vessel dynamics and AAA heterogeneity.
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Noninvasive imaging technologies used in the clinic, such as magnetic resonance
imaging (MRI) and ultrasound (US), are now being used in preclinical AAA research [79]. Research groups have used MRI and US in longitudinal studies to monitor changes in aortic diameter [80–83] and vessel motion [63, 84, 85]. Without the aid
of these noninvasive imaging techniques, studies are typically limited to a single experimental time point per animal. This increases the total number of animals needed
and prevents studying further disease progression once the animal is sacriﬁced. Furthermore, dynamic in vivo measurements such as vessel motion and blood ﬂow are
not possible.
In this paper, we present the results of longitudinal ultrasound studies using the
elastase and AngII apoE −/− animal models to compare the changes in four important
anatomic and biomechanical parameters: aneurysm diameter, aneurysm volume, circumferential cyclic strain, and blood ﬂow velocity. Additionally, we show results from
semiquantitative AAA histological tissue analysis ex vivo to detect changes in elastin
and collagen content for each model. Finally, we demonstrate the use of label-free
nonlinear optical microscopy as a surrogate for histology. Our ﬁndings suggest that
the biomechanical parameters measured here change drastically due to vessel wall remodeling as the aortic diameter and volume increase. By measuring these parameters
in individual AAA rats and mice during disease progression, further in vivo studies
investigating potential therapeutics can be performed.

4.3

Materials and Methods

4.3.1

Animal care and maintenance

Male Sprague Dawley rats (281-347 g; 10-11 weeks old) from Harlan Laboratories
(Indianapolis, IN) and male and female apolipoprotein E-deﬁcient mice (20-36 g; 17
± 7.8 weeks old; B6.129P2-Apoe tm1Unc /J strain) from The Jackson Laboratory (Bar
Harbor, ME) were used for elastase perfusion and osmotic pump studies, respectively.
All animals were allowed free access to standard rodent chow and water. We recorded
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animal weights prior to surgery, after surgery, and on subsequent study days. All
studies lasted up to 29 days post-surgery at which point animals were euthanized
(isoﬂurane and carbon dioxide asphyxiation). The Purdue Animal Care and Use
Committee approved all experiments.

4.3.2

Elastase perfusion surgery in rats

We induced AAAs in Sprague Dawley rats (n=11) using an intra-aortic elastase
perfusion procedure described previously [40]. Brieﬂy, the infrarenal aorta was surgically exposed in an anesthetized rat (2% isoﬂurane) and proximal and distal aortic
sites were temporarily ligated with 6-0 silk sutures. Type I porcine pancreatic elastase solution (E1250, Lot number SLBD0685V; Sigma Aldrich, St. Louis, MO) was
pressure- perfused (100 mm Hg) for 30 minutes into the ligated aorta through an
aortotomy proximal to the aortic bifurcation. We tested both low (0.440.48 U/mL;
n=6) and high (25 U/mL; n=5) elastase solutions.

4.3.3

Implantations of angiotensin II-loaded miniosmotic pumps in
mice

We used a second AAA model [41] in which continuous AngII infusion in apoE −/−
mice induces suprarenal AAA formation typically between 3 and 14 days after implantation of miniosmotic pumps (ALZET Model 2004; DURECT Corporation, Cupertino, CA). AngII powder (MW: 1046.19; Bachem, Torrance, CA) was solubilized
in 0.9% sodium chloride and loaded into miniosmotic pumps for systemic hormone
delivery (1000 ng/kg/min infusion rate and 28-day duration) following subcutaneous
implantation in the dorsum of mice (n=7).
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4.3.4

Small animal ultrasound imaging

We performed in vivo ultrasonography of rats and mice kept unconscious under
inhalant anesthesia (1 − 2.5% isoﬂurane). Prior to imaging, animals were positioned
supine on an adjustable heated stage and sterile eye lubricant was applied to each eye.
We noninvasively monitored heart and respiration rate through stage electrodes and
body temperature using a rectal probe. Hair on the ventral abdomen was removed
with a depilatory cream and warm transmission ultrasound gel was applied on the
exposed skin surface.
For detection and longitudinal monitoring of aortic diameter, aortic volume, vessel
wall motion, and blood ﬂow dynamics, we used a high-resolution small animal ultrasound system (Vevo2100 Imaging System; VisualSonics, Toronto, ON, Canada). We
acquired transaxial and longitudinal ultrasound data prior to surgeries (day 0) and
at days 3, 7, 14, 21, and 28 post-surgery using VisualSonics linear array transducers
MS550D (25 − 55 MHz, 40 MHz center frequency) and MS250D (13 − 24 MHz, 21
MHz center frequency) in mice and rats, respectively. The transducer was positioned
perpendicular to the animal and held in contact with the gel during imaging. We adjusted the angle of the stage as necessary to allow optimal visualization of the aorta
in the long and short axes. We used anatomical landmarks, such as the inferior vena
cava, renal veins, and aortic bifurcation, for orientation and the presence of vessel
wall motion for discriminating arterial from venous ﬂow.
High-resolution, two-dimensional cine loops in brightness mode (B-mode; 300
frames), motion mode (M-mode; ﬁve-second acquisition), pulsed wave (PW), and
color Doppler (ﬁve-second acquisitions) were acquired in aortic regions with and without vessel expansion. We adjusted the transducer beam angle and PW Doppler angle
(30 − 60 degrees from the vertical) in order to accurately detect the magnitude and
direction of blood ﬂow in the selected aortic area. Additionally, we used respiration and cardiac gating for transaxial B-mode volumes (0.19 mm step size) of the
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infrarenal aorta of rats (3 cm scan distance) and the suprarenal aorta of mice (1.5 cm
scan distance).

4.3.5

Blood pressure measurements

We measured blood pressures from the tails of conscious apoE −/− mice in the
study prior to pump implantation and on days 3, 14, and 28 after implantation. Prior
to implantation, mice were acclimated to restraint holders and the tail cuﬀs used for
taking blood pressure measurements (CODA 2 Channel Standard, Kent Scientiﬁc,
Torrington, CT).

4.3.6

Ultrasound analysis

We analyzed all ultrasound data (days 0, 3, 7, 14, 21, and 28) from rats and
mice with Vevo2100 software (VisualSonics) to determine maximum aortic diameter,
AAA true and false lumen volumes, circumferential cyclic strain, and mean blood ﬂow
velocity. All measurements on cine loops were made in quintuplicate and averaged.
B-mode volumes of the abdominal aorta were segmented in a semiautomated
fashion by drawing serial contours (step size: 760 µm and smaller). The length and
location of maximum AAA diameter in relation to the right renal artery in mice
or the aortic bifurcation in rats were used to guide volume measurements at earlier
time points. In other words, earlier day volumes were segmented over the same
anatomical length and started at the same anatomical position. In the AngII apoE −/−
mice, volumes of both the AAA lumen and total AAA (including the vessel wall)
were segmented individually. False lumen volumes were calculated as the diﬀerence
between the total AAA and the true lumen.
We further calculated eﬀective maximum diameter from these segmented volumes.
We identiﬁed the slice showing maximal aortic cross-sectional area and calculated effective maximum diameter using the equation for area of a circle and the measured
area. In three instances, aortic diameter measurements from long-axis B-mode were

21
substituted for the displayed eﬀective maximum diameter measurements, as the collected volumes were not clear enough to provide eﬀective maximum diameter values.
Aortic diameters in areas of maximal vessel expansion as seen in long axis were
also measured from high-temporal resolution B-mode cine loops (50 frames/sec for
MS250D; 233 frames/sec for MS550D). We employed a straight-line distance measurement tool to calculate the length from the posterior to anterior vessel wall at
peak systole and end diastole, corresponding to systolic (DS ) and diastolic (DD ) diameters. Mean aortic diameter (DM ) for a given animal on a given day was calculated
as follows:
1
DM = [DS − DD ] + DD
3

(4.1)

We calculated circumferential cyclic strain values from M-mode diameter measurements in areas showing maximum vessel expansion seen in long axis. The distance
between two lines of strong specular reﬂection seen in the anterior and posterior vessel
walls was used to determine maximum and minimum vessel wall displacement. These
respective values correspond to the timing of peak systole and end diastole. In order
to calculate Green-Lagrange circumferential cyclic strain, the following formula was
used [85, 130]:
1 DS 2
[(
) − 1] ∗ 100%
2 DD

(4.2)

Curvature in the suprarenal aorta, however, requires a geometric correction to
be applied to the initial diameter (Di ) measurements made for the AngII apoE −/−
mice. The angle (θ) between vertical and a line segment perpendicular to anterior and
posterior vessel walls in the AAA was determined. Prior to the circumferential cyclic
strain calculation above, the following equation was used to calculate geometrically
corrected diameter (Dc ) values:
Dc = Di ∗ cos(θ)

(4.3)
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Mean blood ﬂow velocity values were calculated from velocity waveforms on PW
Doppler images. A velocity waveform area analysis tool was used to calculate this
value over individual cardiac cycles displayed on a velocity/time plot.

4.3.7

Animal perfusion and dissection

After euthanasia, animals underwent a series of pressure perfusions through the
left ventricle (transcardial perfusion). We successively perfused 0.9% sodium chloride (to ﬂush the systemic vasculature), 4% paraformaldehyde (to ﬁx the aorta), and
1% molten agarose (to preserve vessel patency upon cooling) using a syringe pump
connected to a feeding needle or polyethylene tube (0.64 mm outer diameter) inserted in the left ventricle. The heart, aorta, and kidneys were later dissected from
the animal and ﬁxed in 4% paraformaldehyde for 24 hours. Aortic tissue was kept
in phosphate-buﬀered saline until gross vessel dissection (four 2-3 mm-long crosssections) in proximal, aneurysmal, and distal areas and then held in 70% alcohol
until processing.

4.3.8

Aortic tissue histology and staining

Aortic segments were paraﬃn-embedded, thin-sectioned (5 µm), and adjacent sections stained with hematoxylin and eosin (H&E), Verhoeﬀ Van-Gieson (VVG)/hematoxylin,
and Massons trichrome (MTC) as per standard protocols. The latter two stains were
used to diﬀerentiate elastin bands (black) and collagen ﬁbers (blue), respectively, from
surrounding structures. Stained tissue sections were scanned at 40x magniﬁcation.

4.3.9

Nonlinear optical microscopy

H&E-stained aortic sections were imaged using two nonlinear optical (NLO) microscopy techniques, two-photon excitation ﬂuorescence (TPEF), and second harmonic generation (SHG) for label- free imaging of endogenous macromolecules. A
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custom-built femtosecond laser system (140 fs pulse width; 80 MHz repetition rate)
was used for simultaneous TPEF/SHG imaging at 800 nm excitation (Chameleon
Ultra I; Coherent, Santa Clara, CA). A tightly focused beam (39 mW average power)
was directed through a 20x air or 60x water immersion objective on an inverted microscope (IX70, Olympus, Melville, NY). FV300 software (Olympus, Melville, NY) was
used for image capture and thresholding of forward-emitted SHG and back-reﬂected
TPEF autoﬂuorescence signals detected by separate photomultiplier tubes (PMTs).
A dichroic mirror (550dcxr, Chroma Technologies, Rockingham, VT) separated the
excitation beam from back-reﬂected TPEF signal. Band-pass ﬁlters were chosen according to a previous publication focused on label-free imaging of collagen and elastin
in swine arteries [131].

4.3.10

Image processing and semiquantitative analysis

VVG images of aneurysmal and control (i.e., proximal or distal) aortic sections
from the suprarenal (AngII apoE −/− mice) or infrarenal (elastase rats) aortas were
analyzed using a semiautomated thresholding technique described previously [85] to
acquire semiquantitative measures of elastin area. The thresholding technique was
further modiﬁed to generate binary images of collagen pixels from corresponding MTC
images. Hand-selected regions of interest were placed in three locations on the aortic
adventitia of each image to measure the density of pixels corresponding to collagen
and averaged.

4.3.11

Statistical analysis

We used paired t-tests and two-sample t-tests in order to assess statistical signiﬁcance of a parameter between two time points or between AAA and a healthy region.
Additionally, we used one-way analysis of variance to test for signiﬁcant diﬀerences
in mean systolic or diastolic blood pressure at multiple times postimplantation as
compared to baseline (Dunnett’s test). Signiﬁcance at α=0.05 was used for all tests.
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4.4

Results

4.4.1

Small animal ultrasonography of AAAs enables longitudinal monitoring of aortic diameter expansion and volume growth over time

Two-dimensional and three-dimensional B-mode scans enabled us to comprehensively image aortas in AngII apoE −/− mice and high-concentration-elastase rats in the
short- (transaxial) and long-axis (sagittal) orientations. Figure 4.1 shows representative B-mode images of the planes of section where the maximal aortic cross-sectional
area was found at days 0 and 28 for the high-concentration-elastase rat (Figure 4.1.a)
and AngII apoE −/− mouse (Figure 4.1.b) studies. During the course of the studies,
we clearly identiﬁed areas of local aortic expansion (arrows in Figures 4.1.a and 4.1.b
for day 28) and tracked this increase in eﬀective maximum diameter (Figures 4.1.a
and 4.1.b, graphs). Proximal and distal aortic areas with normal vessel morphology
were imaged and showed no overall increase in diameter (data not shown).
Table 4.1 shows the average increases in eﬀective maximum diameter by the
end of the study. Over 28 days, AAAs in high-concentration-elastase rats grew
181±13.8% relative to baseline (Figure 4.1.a), and those in AngII apoE −/− mice grew
by 126±10.5% (Figure 4.1.b). High-concentration-elastase rats exhibited obvious formation of AAAs postsurgery and a progressive increase (94 µm/day on average) in
eﬀective maximum diameter (Figure 4.1.a) thereafter (1.78 − 3.39 mm larger at day
28 than at baseline, 95% CI; p<0.05). Low-concentration-elastase rats, however, did
not show signiﬁcant vessel expansion by ultrasound or a signiﬁcant change in eﬀective
maximum diameter over 28 days (Table 4.1). Given the spontaneous development of
initial aortic expansion in the AngII apoE −/− model (between days 3 − 14), maximum aortic diameter was 86.7±8.36% larger at day 14 imaging on average (Figure
4.1.b) with a growth rate of 198 µm/day thereafter until day 28.
We further measured AAA volumes from segmented three-dimensional B-mode
scans (Table 4.1). In high-concentration-elastase rats, there was a noticeable volume
expansion in the perfused region as compared to low-concentration-elastase rats. Vol-
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ume/length values for the high-concentration-elastase rats increased by 516±96.0%
after 28 days (Figure 4.1.c). In AngII apoE −/− mice, we observed saccular AAAs
with volume/length values increasing by 297±42.5% for AAA total volumes (Figure
4.1.d). False lumens were identiﬁed at day 3 (n=2), day 7 (n=2), and day 14 (n=3)
imaging. Between days 3 and 28, these volumes increased in size by 774±512% overall. As well, we found that there was a signiﬁcant change in the percentage of AAA
volume attributable to the false lumen (20.8±11.8% versus 57.1±10.2%, respectively;
p<0.001).

4.4.2

Circumferential cyclic strain rapidly decreases in AAAs

We observed abrupt changes in vessel wall displacement and Green-Lagrange circumferential cyclic strain values in high-concentration-elastase rats (Figure 4.2.a,
graph) and AngII apoE −/− mice (Figure 4.2.b, graph) at day 3 relative to baseline
(69.9±26.2%, p=0.0048; 49.7±11.9%, p=0.026, respectively). These values decreased
in the suprarenal aortas of some mice where vessel motion had diminished, but initial
aortic expansion had not yet occurred. Between days 3 and 28, we measured continued reductions in these values (43.9±28.3%, p=0.0048; 60.7±19.6%, p=0.054, respectively) and visualized stiﬀer vessel walls in AAAs (see Supplementary Videos 1 and 2 of
the Supplementary Material available online at http://dx.doi.org/10.1155/2015/413189).
In low-concentration-elastase rats, we also found that the Green-Lagrange circumferential cyclic strain values signiﬁcantly decreased over 28 days (Table 4.1) likely due to
mechanical damage from the pressurized infusion during surgery independent of AAA
formation. Circumferential cyclic strain values remained stable in proximal and distal
aortic areas of all rats and mice over 28 days (data not shown). Blood pressure data
acquired in live AngII apoE −/− mice showed that on average they became hypertensive as early as day 3 after implantation, although this increase was not statistically
signiﬁcant (p<0.1). The tail cuﬀ technique is inherently noisy, meaning that the increase in blood pressure did not reach signiﬁcance of p<0.05. However, longitudinal
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measurements (Figure 4.2.b inset) provided evidence of continued hypertension in the
animals over the course of the study.

4.4.3

Mean blood ﬂow velocity decreases in both AAA models and recirculates in suprarenal AAAs

With progression of disease in the high-concentration-elastase rats, we found that
mean blood ﬂow velocity progressively decreased over time (Figure 4.3.a, graph).
Overall decreases in this value at areas adjacent to an AAA were visually evident
(online Supplementary Videos 3 and 4) and measurable (Figure 4.3.a, velocity waveform plots). We found comparable reductions in AAA mean blood ﬂow velocity (Table
4.1) at day 28 relative to day 0 (76.9±29.1%; p<0.05) and to adjacent healthy regions
at day 28 (73.5±27.3%; p<0.001). In low-concentration-elastase rats, we found that
the mean blood ﬂow velocity in the perfused region had slightly decreased after 28
days (p=0.0532) (Table 4.1). PW Doppler scans on AngII apoE −/− mice did not
provide a complete dataset. However, we clearly observed a shift to complex aortic
ﬂow patterns by days 21 and 28 imaging (online Supplementary Video 5). Smaller
areas of reduced or recirculating ﬂow were seen adjacent to focal dissection points
(online Supplementary Video 6). As a result, we measured marked reductions in
mean blood ﬂow velocity and a change in ﬂow direction at day 28 relative to day 0
in mice (Figure 4.3.b, velocity waveforms). We found comparable reductions in AAA
mean blood ﬂow velocity at day 28 relative to day 0 (49.6±26.9%; p=0.192) and to
adjacent healthy regions at day 28 (52.9±28.9%; p<0.05) (Table 4.1).

4.4.4

AAAs exhibit elastin degradation and collagen deposition by histological staining

Dissections of rats and mice showed the anticipated shape of AAAs in situ as was
seen by ultrasound prior to sacriﬁce (Figures 4.4.a and 4.4.b). The short-axis B-mode
images in Figures 4.4.c and 4.4.d reveal the inner vessel walls and maximum cross-
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sectional diameters and areas in each AAA model prior to dissection. MTC staining
for collagen (Figures 4.5.a and 4.5.b) and VVG staining for elastin (Figures 4.5.c and
4.5.d) revealed changes in the distribution and overall content of these proteins in the
AAA wall. The most noticeable changes are the degradation and loss of elastin bands
in high-concentration- elastase rats and signiﬁcant collagen deposition in the AngII
apoE −/− mice. Collagen accumulates as disorganized collagen ﬁbers, as is seen with
ﬁbrosis, and fails to support the aortic wall architecture [99]. We found that reductions in elastin content were statistically signiﬁcant using high elastase concentration
(90±3.9%; p=0.002) relative to healthy regions (Figure 4.5.e). Low-concentrationelastase rats exhibited a smaller amount of elastin degradation (49±3.1%; p=0.122)
in some of the aortas (images not shown). Additionally, the morphology of collagen changed in both low- and high-concentration-elastase rats, appearing stringier
and more detached than healthy collagen ﬁbers. In these areas, we found a statistically signiﬁcant decrease in the amount of collagen in high-concentration-elastase
rats (63±10% reduction; p=0.04). Collagen in low-concentration-elastase rats also
decreased (54±11%), albeit not signiﬁcantly (p=0.13).
AngII apoE −/− mice consistently showed collagen deposition in and around transmural hematomas resulting from false lumen formation. We found an 82±27% increase (p=0.0611) in collagen content in these areas relative to healthy regions (Figure 4.5.f). Conversely, our measurements of elastin content in proximity to the
hematomas showed similar levels to those for healthy regions (p=0.73), as a focal
dissection point where elastin had been degraded was not always seen in our sections.

4.4.5

Nonlinear optical microscopy enables label-free imaging of elastin
and collagen in ex vivo AAA tissue

We also tested the use of NLO microscopy to detect elastin and collagen in AAA
tissues. We found that AAAs from elastase rats showed changes in TPEF signal
according to elastase concentration. Elastin ﬁbers were clearly absent or degraded in
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elastase perfused aortic tissue (white arrows in Figure 4.6.a), similar to the ﬁndings
seen with VVG staining. In contrast, healthy regions demonstrated strong autoﬂuorescence signal due to the presence of elastin. The emission ﬁlter used also detected
autoﬂuorescence signal from agarose gel in the aortic lumen (asterisks in Figure 4.6)
and adventitial proteins, likely collagen and ﬁbrin. Adventitial collagen, as detected
by SHG signal, was observed in both types of AAAs (black arrows in Figure 4.6).
This signal was visually apparent in and around transmural hematomas in the AngII
apoE −/− model where collagen deposition is pronounced. In the adventitia of elastaseperfused aortas, a change in overall SHG signal intensity and spatial distribution may
also be occurring.

4.5

Discussion
This work demonstrates that we can sensitively detect and monitor biomechan-

ical changes occurring during progression of AAAs in both the elastase and AngII
apoE −/− models. We showed reductions in both circumferential cyclic strain and
mean blood ﬂow velocity within AAAs relative to adjacent healthy regions. We also
found substantial elastin fragmentation and collagen deposition with label-free microscopy. Taken together, these results suggest that diﬀerences in AAA growth,
strain, and blood ﬂow velocity are useful parameters that reveal time-dependent
changes in each model.
While aortic diameter measurements are standard for determining maximum aortic expansion in both human [1, 132, 133] and small animal [80–83, 134, 135] AAAs,
the data from this study suggest that aortic volumes may be a more useful metric
for characterizing aneurysm expansion. Indeed, simple diameter measurements from
B-mode images depend on the acquisition location and measurement technique. Aortic volumes, on the other hand, should be less dependent on location and technique
as the entire aorta can be acquired in one three-dimensional volume. This technique
can also account for changes in the length of a growing AAA not exhibiting accom-
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panying increases in diameter. Similar to the volumetric ultrasound images others
have collected [68,86], we observed an increase in the length of AngII apoE −/− AAAs.
The average AAA volume-to-length ratios in our AngII apoE −/− mice (mean±SE;
2.8±0.3 mm2 at day 28) compare well with a previous report using MRI (mean±SD;
2.5±0.6mm2 at day 28 [63]). Likewise, these values for the high-concentration-elastase
rats (8.7±1.6 mm2 at day 28) compare well to elastase-perfused mice (1.1±0.2 mm2
at day 28 [63]) when accounting for animal weight (rats are roughly 10 times bigger
than mice). We also observed several mice and rats in this study where the diameter
measurements plateaued, but the volume/length ratio continued to increase (Figure 4.1). These results suggest that in some cases the aneurysms were lengthening
without signiﬁcant diameter expansion. A recent article also used three-dimensional
ultrasound but for ex vivo measurements of AAAs from AngII apoE −/− mice [136].
These volumes, however, were segmented over a short 2 mm length in all cases, making a direct comparison to our measurements with variable lengths diﬃcult. Future
studies to compare volumes of the same AAAs in vivo and ex vivo by ultrasound
may be warranted, as the changes in the overall size and shape of AAAs following
transcardial perfusion are not fully known.
With both AAA models, we noted that circumferential cyclic strain sometimes
decreased independently of vessel expansion. In AngII apoE −/− mice, four animals
had reductions in circumferential cyclic strain (>33%) but normal eﬀective maximum
diameters (<150% baseline) at day 3. Three animals showed abrupt aortic expansion
in parallel with large reductions in circumferential cyclic strain (>75%). Consistent
with this ﬁnding is blood pressure data, which shows sustained hypertension starting
at day 3. This is expected with AngII infusion, leading to a shift in the loading
response up the stress-strain curve. At these early time points we would not expect there to be substantial vessel remodeling. Further studies with greater numbers
of mice are needed to improve our understanding of the relationship between vessel
expansion and circumferential cyclic strain reductions in AngII-induced AAAs. For
rats infused with low concentration elastase, we observed reductions in circumferen-
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tial cyclic strain despite negligible increases in aortic diameter or volume over 28 days
(Table 4.1). This may be due to pressure-induced vessel damage, ligation of branching
vessels, or other eﬀects of the surgical procedure. Two groups have previously carried
out studies to track changes in circumferential strain values in the aortas of AngII
apoE −/− mice [63, 84]. Favreau et al. [84] calculated linear or Cauchy strain values
using ultrasound and found a roughly 40% reduction in cyclic strain in the supraceliac
aorta at day 3 (similar to the circumferential cyclic strain reduction of 49.7±11.9%
we observed). Ideally, the nonlinear strain components accounted for by circumferential cyclic strain should not be neglected since strain values up to 25% cannot be
considered small [130]. Goergen et al. [63] calculated circumferential cyclic strain
values from magnetic resonance angiography (MRA) images of elastase (19.4±2.5%)
and AngII apoE −/− (20.8±4.2%) mice at baseline in relative agreement with our
values (15.2±1.2% in high- and low-concentration-elastase rats and 12.6±1.4% in
AngII apoE −/− mice). However, we observed comparatively larger reductions by day
28. High-concentration-elastase rats in our study showed an 83.1±31.1% reduction,
while their elastase mice had a 44.8±0.1% decrease. AngII apoE −/− mice in this
study showed an 80.2±21.6% reduction, while the other paper showed a 52±16.3%
decrease in this same model. This diﬀerence may be due to the higher spatial resolution and fundamental contrast diﬀerences between the Vevo2100 ultrasound system
and MRA using a 4.7 T magnet. As MRA highlights unsaturated spins or nuclei
from ﬂowing blood, its disadvantage lies in accurately visualizing solid aneurysm regions where blood ﬂow is not present. For the AngII apoE −/− mice, MRA showed
maximal reductions in circumferential cyclic strain and increases in aortic diameter
coincided in the days 7 to 14 interval [63]. This delay compared to our ﬁndings of
earlier reductions in strain may be attributable to the fact that we primed the pumps
in physiological saline solution for at least 12 hours prior to implantation.
Many previous eﬀorts have used qualitative assessments of VVG- and MTCstained vessels to conﬁrm elastin breakage and collagen deposition [137, 138]. We
focused on a quantitative approach that would provide a more robust comparison
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between suprarenal AAAs and infrarenal AAAs from high- and low-concentrationelastase rats. Goergen et al. previously quantiﬁed diﬀerences in elastin content of
VVG-stained aortas [63] and found that the anterior wall in elastase-perfused mice
showed signiﬁcantly greater elastin loss than the posterior wall in the same region.
We implemented a similar code with the addition of vessel wall collagen analysis in
order to determine the magnitude of change in AAA areas relative to adjacent healthy
areas.
The use of NLO microscopy (SHG and TPEF) was included in these studies as it is
a powerful label-free technique that can be used to study vascular diseases. Changes in
the content and morphology of elastin and collagen are clearly tied with inﬂammatory
and proteolytic eﬀects occurring in AAA progression. Future studies could beneﬁt
from three-dimensional mapping and quantiﬁcation of elastin and collagen ﬁbers. Cui
et al. demonstrated the use of multiphoton microscopy for volumetric analysis of these
macromolecules in the aorta and skin of a murine Marfan model [139], while Haskett
et al. determined vessel ﬁber alignment after mechanical testing of AAAs [140]. Le
et al. originally measured the emission spectra of collagen and elastin in atherosclerotic Ossabaw pig arteries using a similar microscopy set-up [131]. Taken together,
these previous studies and our work suggest that a label-free imaging approach has
several advantages over standard histological staining and microscopy. Primarily, it
obviates the need for tissue processing and chemical staining. The tissue can be imaged in a near-native state and variability in tissue stain application is no longer an
issue. It also permits analysis of thicker tissue sections than is feasible with confocal
microscopy. Similar to how volumetric ultrasound measurements of AAAs provide
more information than simple two-dimensional measures, the use of volumetric quantiﬁcation from thicker tissue specimens could also be useful when imaging ex vivo
sections.
There are several limitations in the present study. First, the presence of abdominal
gas in animals can disrupt ultrasound imaging. If not resolved within a few minutes,
we changed the orientation of the transducer relative to the body to minimize this
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interference. However, this reorientation sometimes limited our ability to visualize
all regions of the aorta and to detect accurate blood ﬂow patterns. Additionally,
the Doppler measurements in the study had large variations. This was likely due to
variations in the Doppler angle when acquiring PW images. Thus, tilting and rotating
the animals could be done in order to optimize the Doppler angle for long-axis PW
and color Doppler measurements in the aorta where the vessel often runs parallel to
the transducer.

4.6

Conclusions
We carried out longitudinal studies in vivo in order to image and measure several

parameters relevant to AAA development. Elastase-perfused rats and AngII apoE −/−
mice exhibited large reductions in circumferential cyclic strain and mean blood ﬂow
velocity over 28 days. These parameters had temporal diﬀerences in each model that
were not necessarily correlated with increases in eﬀective maximum diameter or AAA
volume. The results suggest that vessel strain and blood ﬂow are important metrics
and may be indicative of underlying disease processes in AAAs. We used small
animal ultrasound for this study, as it oﬀered us rapid imaging speed and versatility
in imaging acquisitions and was relatively inexpensive compared to other tomographic
imaging. Furthermore, semiquantitative histology and nonlinear optical microscopy
allowed us to further characterize our ﬁndings ex vivo. We feel that quantifying
macromolecular changes in elastin and collagen is helpful for sensitively characterizing
AAAs from both the elastase and AngII apoE −/− models. Future studies could
use these methods to investigate mechanisms in pathogenesis and treatment eﬀects
relevant to AAAs and other cardiovascular diseases.
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Fig. 4.1.: Circumferential cyclic strain decreases over 28 days. Representative longaxis M-mode tracings (days 0 and 28) and longitudinal measurements of circumferential cyclic strain at site of AAA for high-concentration-elastase rats (a) and AngII
apoE −/− mice (b). Inset in (b): longitudinal measurements of systolic and diastolic
blood pressure in AngII apoE −/− mice.
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Fig. 4.2.: Circumferential cyclic strain decreases over 28 days. Representative longaxis M-mode tracings (days 0 and 28) and longitudinal measurements of circumferential cyclic strain at site of AAA for high-concentration-elastase rats (a) and AngII
apoE −/− mice (b). Inset in (b): longitudinal measurements of systolic and diastolic
blood pressure in AngII apoE −/− mice.
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Fig. 4.3.: Mean aortic blood ﬂow velocity decreases after 28 days. Representative velocity waveforms on long-axis PW Doppler acquisitions (days 0 and 28) and
corresponding measurements of mean blood ﬂow velocities at site of AAA in highconcentration-elastase rats (a) and AngII apoE −/− mice (b).

Fig. 4.4.: Gross dissection of AAAs shows shape of AAAs detected by B-mode images.
End-of-study dissection images of AAAs in situ and short-axis B-mode images at day
28 from a high-concentration-elastase rat ((a), (c)) and an AngII apoE −/− mouse
((b), (d)). B-mode images taken at the approximate anatomical locations marked by
green dashed lines ((a) and (b)). White dashed lines indicate locations selected for
histology. Scale bars: 5 mm (a); 2 mm (b); 2 mm (c); and 1 mm (d).
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Fig. 4.5.: Histological staining reveals qualitative and semiquantitative diﬀerences
in elastin and collagen content of AAAs. Representative MTC ((a), (b)) and VVG
((c), (d)) images of AAA tissue from a high concentration elastase rat ((a), (c)) and
an AngII apoE −/− mouse ((b), (d)). Normalized measurements of mean elastin and
collagen content ((e), (f)) in high- (n=5) and low- (n=4) concentration-elastase rats
(e) and AngII apoE −/− mice (n= 6) (f). Controls (n=3 in each group) are sections
with healthy regions. Scale bars: 200 µm at low and 100 µm at high magniﬁcation.
Level of magniﬁcation: 8x ((a), (c)) and 2x ((b), (d)) relative to low magniﬁcation.
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Fig. 4.6.: Nonlinear optical microscopy provides a label-free approach for examination
of AAA tissue morphology and protein content. SHG (green), TPEF (red), and
merged SHG/TPEF nonlinear optical images of representative aortic tissue sections
from healthy and AAA regions in low- and high-concentration-elastase rats (a), and
AngII apoE −/− mice (b). Scale bars: 100 µm. Black arrows point to adventitial
collagen; white arrows point to degraded elastin bands; and asterisks indicate agarose
gel in lumen.

Data are given as mean±SE. BFV: blood ﬂow velocity; NA: not applicable.

Statistical signiﬁcance shown for α=0.05:
*versus the vessel measurement at day 0;
ˆversus healthy region measurement at day 28;
◦
versus healthy region measurement at day 0.

Eﬀective maximum diameter (mm)
Aortic maximum diameter (mm)
Volume/length (mm2 )
Length (mm)
False lumen volume (mm3 )
Circumferential cyclic strain (%)
Mean BFV (perfused region/AAA) (mm/s)
Mean BFV (healthy region) (mm/s)

Elastase rats
Elastase rats
(0.44 - 0.48 U/mL)
(25 U/mL)
(mean±SE (n=6))
(mean±SE (n=5))
Day 0
Day 28
Day 0
Day 28
1.48±0.04 1.55±0.05 1.43±0.03 4.02±0.29*
1.15±0.09 1.46±0.14 1.05±0.03 3.85±0.49*
1.72±0.06 2.06±0.29 1.41±0.06 8.65±1.57*
6.92±0.40 6.92±0.40 7.88±0.83 7.88±0.83
NA
NA
NA
NA
17.28±1.34 6.18±0.72* 12.67±1.39 2.14±0.27*
85.3±29.6◦
NA
230±28.4
NA
370±55.4
230±28.4
318±11.3
322±41.9*

AngII apoE −/− mice
(1000 ng · kg −1 · min−1 )
(mean±SE (n=7))
Day 0
Day 28
1.01±0.05 2.27±0.15*
0.95±0.05 2.06±0.13*
0.70±0.08 2.76±0.26*
7.07±0.65 7.07±0.65
0
11.1±1.57*
12.6±1.4
2.5±0.61*
NA
189±99.9ˆ
374±44.7
401±57.3

Table 4.1.: Summary of values measured at days 0 and 28 in low- and high-concentration-elastase rats and AngII apoE −/−
mice
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5. VARIABILITY IN THE MORPHOLOGY AND
HEMODYNAMICS OF DISSECTING ABDOMINAL
AORTIC ANEURYSMS
This chapter contains the contents of a published manuscript entitled “ Multi-Modality
Imaging Enables Detailed Hemodynamic Simulations in Dissecting Aneurysms in
Mice”. I have made edits to the formatting and wording to match the rest of the
dissertation. The published version as well as supplemental movies are accessible
here: https://ieeexplore.ieee.org/document/7843618

5.1

Abstract
A multi-modality imaging-based modeling approach was used to study complex

unsteady hemodynamics and lesion growth in a dissecting abdominal aortic aneurysm
model. We combined in vivo ultrasound (geometry and ﬂow) and in vitro optical
coherence tomography (OCT) (geometry) to obtain the high resolution needed to
construct detailed hemodynamic simulations over large portions of the murine vasculature, which include ﬁne geometric complexities. We illustrate this approach for
a spectrum of dissecting abdominal aortic aneurysms induced in male apolipoprotein
E-null mice by high-dose angiotensin II infusion. In vivo morphological and hemodynamic data provide information on volumetric lesion growth and changes in blood
ﬂow dynamics, respectively, occurring from the day of initial aortic expansion. We
validated the associated computational models by comparing results on time-varying
outlet ﬂows and vortical structures within the lesions. Three out of four lesions exhibited abrupt formation of thrombus, though diﬀerent in size. We determined that
a lesion without thrombus formed with a thickened vessel wall, which was resolvable
by OCT and histology. We attribute diﬀerences in ﬁnal sizes and compositions of
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these lesions to the diﬀerent computed ﬂow and vortical structures we obtained in
our mouse-speciﬁc ﬂuid dynamic models. Diﬀerences in morphology and hemodynamics play crucial roles in determining the evolution of dissecting abdominal aortic
aneurysms. Coupled high resolution in vivo and in vitro imaging approaches provide
much-improved geometric models for hemodynamic simulations. Our imaging-based
computational ﬁndings suggest a link between perturbations in hemodynamic metrics
and aneurysmal disease heterogeneity.

5.2

Introduction
The increasing availability of genetically altered, pharmacologically treated, and

surgically modiﬁed mice has rendered the mouse the animal model of choice in many
studies of vascular biology and mechanics. As an illustrative example, chronic infusion of angiotensin II (AngII) in male apolipoprotein E-null (apoE −/− ) mice yields a
reproducible model of dissecting aortic aneurysm, often including a false lumen with
intramural thrombosis [41,141]. Given that hemodynamics is critical to the formation
and growth of aneurysms, dissections, and thrombus [142, 143], there is strong motivation to develop sophisticated data-driven models of the associated changes in blood
ﬂow, pressure, and wall mechanics. Yet, the small dimensions of the murine vasculature combined with the high heart rate present signiﬁcant experimental challenges,
both in vivo and in vitro.
The purpose of the present study is to implement a multi-modality imaging based
modeling approach to investigate the heterogeneity of blood ﬂow dynamics and growth
in the AngII model. We show that a combination of in vivo data from high-frequency
ultrasound (US), quantifying geometry and blood ﬂow, with in vitro data from optical
coherence tomography (OCT), quantifying ﬁne geometry within the lesion, enables
sophisticated three-dimensional computational models suitable for detailed studies
of the hemodynamics in the AngII infusion model. As representative examples, we
present US-OCT-based models and simulations of the suprarenal abdominal aorta
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(SAA) for one mouse representing a modest dilation of the wall, with no visible thrombus, as well as for three mice representing progressively severe dissecting aneurysms
having diﬀerent sized false lumens and varying degrees of intramural thrombus. It is
shown that hemodynamic simulations over a cardiac cycle can be tuned to capture
well the ﬂow proﬁles in the associated outlet vessels (infrarenal aorta, renal arteries, celiac artery, and superior mesenteric artery), thus increasing conﬁdence in the
simulations for other regions, including the false lumen. Qualitative comparisons of
measured and computed ﬂows within the lesions further demonstrate the goodness
of the mouse-speciﬁc models. We submit that this multi-modality imaging approach
can oﬀer considerable advantages for informing hemodynamic simulations of complex
conditions in the murine vasculature.

5.3

Materials and Methods

5.3.1

Animal study

Male apoE −/− mice on a C57BL/6 background (B6.129P2-Apoe tm1Unc /J strain)
were obtained from The Jackson Laboratory (Bar Harbor, ME). Animal weights were
recorded before and just after surgical implantation of a mini-osmotic pump as well as
prior to each imaging session. Mice had access to standard rodent chow and water ad
libitum at all times excluding the brief post-operative recovery period. We monitored
the mice at 48 hour intervals using high-frequency US for up to 21 days post-surgery,
but euthanized each animal by carbon dioxide inhalation 7 days after the initial
observation of an aortic dissection event in the SAA. The Purdue University Animal
Care and Use Committee approved all animal procedures.

5.3.2

Mini-osmotic pump implantations

Powdered AngII (MW: 1046.19; Bachem, Torrance CA) was solubilized in sterile
0.9% saline and loaded in mini-osmotic pumps (ALZET Model 2004; DURECT Cor-
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poration, Cupertino CA) that were partially primed in 0.9% saline at 37◦ C overnight
prior to surgery. Pumps were implanted subcutaneously on the left dorsum under
sterile conditions for systemic delivery of AngII for up to 21 days at a rate of 1000
ng/kg/min. On the day of surgery, mice were on average 81.3±18 days (68-106 days)
of age and had a body mass of 27.5±1.9 g (25.0-29.7 g). Of the seven mice implanted,
one presented with an expanded aortic wall without dissection (mouse M1) whereas
three developed dissecting aneurysms of the SAA (mice M2 to M4). We identiﬁed
these expansions by US on average 7.5±1.7 days (6-9 days) after implanting the
mini-osmotic pumps. Below, we focus on results from these four animals (M1 to M4),
which represent a natural spectrum of early AngII-induced phenotypes despite all
being harvested 7 days following the initial diagnosis (i.e., approximately 14.5 days
post-surgery).

5.3.3

Ultrasound

We anesthetized the mice with 2.0% isoﬂurane in medical grade air at a ﬂow rate
of 1.5 L/min. We then applied sterile ophthalmic ointment to the eyes, removed hair
from the abdomen with a depilatory cream (Nair, Church & Dwight Inc., Ewing, NJ),
and secured the paws to four gold stage electrodes on an adjustable heated platform.
We monitored heart rate, respiration rate, and body temperature throughout the
imaging session and adjusted the isoﬂurane delivery accordingly (1.0-2.0%).
Warm transmission ultrasound gel was placed on the surface of the abdomen for
imaging. We screened and imaged mice using a high-resolution US system (Vevo2100,
FUJIFILM VisualSonics, Toronto, ON, Canada) with a 256 element linear array
transducer optimized for mouse imaging (MS550D; 25-55 MHz frequency range with
a 40 MHz center frequency and 40-90 µm axial and lateral resolution [67]). This
transducer can achieve a frame rate up to 557 frames per second (one focal zone,
5.08 mm width). We maintained the heart rate around 500-600 beats per minute.
Hence, image acquisition was approximately 62 frames per cardiac cycle, which we
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have shown is suﬃcient to capture the blood velocity or wall motion proﬁles with
each heartbeat (cf. Figures 5.5.a and 5.5.c). This high acquisition rate also enabled
us to use cardiac gating and to collect and compare images at the same point in the
cardiac cycle (i.e., systole, after depolarization and contraction of the ventricles).
Beginning 3 days post-surgery, we brieﬂy scanned each mouse every two days
for initial aortic expansion. For each of the four study mice, we acquired axial,
sagittal, and transaxial three-dimensional image datasets before surgery (baseline),
on the day of diagnosis of SAA expansion (day 0), and at four times after diagnosis
(days 1, 3, 5, and 7). The angle of the stage and/or transducer was adjusted as
necessary to visualize the arterial walls and to detect blood ﬂow through the aorta,
renal arteries, celiac artery, and superior mesenteric artery. We acquired brightness
mode (B-mode) cine loops (50 frames/sec) of the lesion and distal abdominal aorta
in an axial view; aortic volumes were acquired (1.5 cm scan distance; 190 µm step
size) between the diaphragm and left renal artery. We also collected motion mode
(M-mode; ﬁve-second acquisitions) and pulsed wave (PW) Doppler mode cine loops
(ﬁve-second acquisitions) of the SAA in a sagittal view to measure vessel strain and
blood velocity, respectively. For PW Doppler measurements, the transducer beam was
adjusted and the Doppler angle ﬁne-tuned (between 0 and 55 degrees from vertical)
to measure the magnitude and direction of ﬂow through the aorta and branching
vessels. Flow data were also acquired in either a three-dimensional transaxial or
two-dimensional sagittal view. Using the color Doppler mode (10 frames/sec; ﬁvesecond acquisitions), we acquired color-coded maps of the velocity and direction of
blood ﬂow through the aorta and branching vessels. Using the ECG-gated kilohertz
visualization (EKV) mode, we visualized blood ﬂow after acquiring high-temporal
resolution cardiac-gated scans (1000 frames/sec).
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5.3.4

Blood pressure measurements

We measured diastolic and systolic arterial blood pressure while mice were conscious at baseline, on days 3 and 7 post-surgery, and on day 4 post-diagnosis of a
lesion. We included a short acclimation period for the mice to adjust to restraint
holders and tail cuﬀs (CODA 2 Channel Standard, Kent Scientiﬁc, Torrington CT)
before measurement.

5.3.5

Ultrasound analysis

We analyzed 3D B-mode data with Vevo2100 software (FUJIFILM VisualSonics)
to delineate volumes of the true lumen and lesion, including the false lumen and
intramural thrombus. We determined the length of each lesion and the location of
the maximum diameter relative to the right renal artery using segmented volumes
from the ﬁnal imaging session (day 7). Volumes from earlier times were segmented
over the same mouse-speciﬁc lesion length in relation to the right renal artery. True
lumen and total lesion volumes were calculated directly from these segmentations and
total false lumen volumes were calculated as the diﬀerence between these two volumes
at each time. We estimated intramural thrombus volumes as the diﬀerence between
the total false lumen and open false lumen volumes.
For the imaging slice showing the maximal aortic cross-sectional area (A), we
calculated an eﬀective maximum outer diameter (D) using an area measurement tool
and the equation for the area of a circle:
p
D = 2 A/π

(5.1)

We calculated cyclic circumferential Green-type strain (relative to diastole) and
mean blood ﬂow velocity (in systole) from M-mode and PW Doppler data, respectively. Five-second cine loops were exported as DICOM ﬁles and analyzed using a
custom MATLAB script. In M-mode analyses, the script extracted specular lines
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to determine time-averaged peak systolic (dsys ) and end diastolic (ddias ) aortic inner
diameters (mm). In vivo circumferential strains (%) throughout the cardiac cycle
were calculated as:
1 dsys 2
[(
) − 1] ∗ 100%
2 ddias

(5.2)

For PW Doppler analysis, the script extracted blood ﬂow velocity waveforms and
utilized a two tangent intersection method [144, 145] to determine a representative
time-averaged mean blood ﬂow velocity.

5.3.6

Optical coherence tomography (OCT) and co-registration with ultrasound data

Following data collection using US, we euthanized the mouse and gently ﬂushed
the vasculature with 1X PBS (1 mL/min for 5 min) by transcardial perfusion through
the left ventricle. We carefully removed the aorta en bloc, from the heart to the iliac
bifurcation, paying special attention to preserve infrarenal and suprarenal branches,
surrounding connective tissue, and the spine. Specimens were held in ice-cold phosphatebuﬀered saline until ready for in vitro testing.
Each specimen was mechanically characterized using a custom biaxial device and
a well-established in vitro testing protocol [146,147]. This procedure required further
cleaning of loose perivascular tissue and trimming the main aortic branches, which
were tied oﬀ to allow pressurization near in vivo conditions. After mechanical testing
(data reported elsewhere), OCT images with a spatial resolution of 7 µm were acquired at conditions that approximated the in vivo state: 80 mmHg luminal pressure
and the estimated in vivo value of axial stretch as revealed by cyclic force-pressure
data. Preliminary comparisons suggested that such conditions deformed the sample
to dimensions corresponding well to those for which US data were acquired at systole
(i.e., luminal pressures under anesthesia).
The OCT system used in this study is commercially available (Thorlabs, Inc.,
Newton, NJ). Speciﬁcally, we used a high-sensitivity ﬁxed wavelength spectral domain
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system (Callisto, OCTG-900; Thorlabs, Inc.). The scanner had a central wavelength
of 930 nm, which provided a maximum imaging depth of 1.7 mm. The system operated at a 1.2 kHz A-scan imaging frequency with a sensitivity of 107 dB. The scan
objective had a 36 mm focal length and 24.9 mm working distance while providing
a 100 mm2 (10 mm X 10 mm) ﬁeld of view and 5X magniﬁcation (OCT-LK3-BB;
Thorlabs, Inc.). Overall, the system conﬁguration had an 8 µm lateral resolution and
7 µm axial resolution (in air, and up to 5.3 µm in water). Based on prior reports on
the optical properties of isolated aortic segments, all images were acquired using a
refractive index of n = 1.38 [148, 149].
OCT volumes were assembled from 100 equispaced B-scans over the axial length
of the sample (up to 10 mm). A single 2-D B-scan consisted of 512 A-scans (1-D
line scan deﬁning a column of the B-scan image), with 512 pixels per A-scan. Thus,
B-scan images were acquired at a size of 512 X 512 pixels and scaled based on the
ratio of the physical dimensions of the scan. The average scan time per volume was
45 seconds, noting that 4 rotationally symmetric volumes were required to construct
complete cross-sections of the large diameter dissected lesions.
In order to reconstruct a domain suitable for computational hemodynamics, the
OCT data included the region of the SAA containing the dissected aneurysm as well
as the near distal and proximal abdominal aorta. That is, we assumed that the lumen in sections of the vasculature away from the lesion was not altered substantially
(at least from a morphological standpoint) by early disease progression and that the
geometries could be inferred solely from the 3D US datasets. For the geometry of the
dissected region, we instead used information combined from the 7-day in vivo 3D
US and the in vitro OCT imaging. Datasets from the two imaging modalities were
co-registered using the Transforms module of the 3D Slicer open-source software (NAMIC; https://www.slicer.org/). Speciﬁcally, we manually selected two landmarks at
each axial slice containing recognizable branch ostia. The ﬁrst ﬁducial point was
chosen at the branching location; the second one was chosen on a diametrically opposite point on the arterial wall. A least-squares optimization algorithm available in
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3D Slicer was then used to ﬁnd an optimal rigid transformation that matched ﬁducial points on 3D US datasets to corresponding points on OCT datasets. In cases
where the software indicated a least-square residual higher than 0.2, we considered
additional ﬁducial points to correct the misalignment.

5.3.7

Computational ﬂuid dynamics modeling

Merging the co-registered 3D US and OCT datasets provided us with detailed
information on the geometry of the lesion as well as the nearby vasculature. The
combined image resolution was high enough to reconstruct computational domains
suitable for detailed hemodynamic simulations that included the false lumen of the
dissection, with delineation of regions that were thrombosed. Using semi-automatic
segmentation algorithms available in SimVascular, an open source software package
[150], we extracted luminal boundaries at several cross sections along the SAA and
main branches (right and left renal arteries, celiac, and superior mesenteric arteries).
The segmented boundaries were then lofted and merged into 3D domains aligned with
the image datasets (see Figure 5.1).
The complete luminal domain was then discretized into millions of tetrahedral
elements (2,963,215±469,103) as required for computations that include calculation
of wall shear stresses over a cardiac cycle. Speciﬁcally, the unsteady Navier-Stokes
equations that govern the hemodynamics were solved using a stabilized ﬁnite element
method within SimVascular. Consistent with prior studies of murine hemodynamics [86,114], we assumed the vascular wall to be rigid in part because of the increased
stiﬀness associated with aneurysmal disease and hypertension (due to AngII infusion),
and because of the lack of detailed information on regional heterogeneities in material properties. Mouse-speciﬁc measured inlet ﬂow rate waveforms were prescribed
individually at the level of the proximal suprarenal aorta as a Dirichlet boundary
condition (using a Womersley velocity proﬁle [151]) based on PW Doppler measurements taken at the same location. Mouse-speciﬁc outlet boundary conditions were
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prescribed using 3-parameter Windkessel models to mimic eﬀects of the proximal and
distal resistances (Rp and Rd ) and the capacitance (C) of the downstream vasculature that were not included explicitly within the 3D models (see Figure 5.2) [152].
Parameters for each Windkessel circuit were optimally valued to match PW Doppler
measurements in the outlet vessels. Speciﬁcally, total resistance values were chosen to
reproduce the observed ﬂow splits among the diﬀerent branches, and proximal resistances were assumed to be 0.052 times the distal ones [144]. Capacitance values were
calculated using a derivative-free optimization scheme built around a 1D surrogate
model of wave propagation along the centerline geometry (Figure 5.2). We used the
1D solver included in Nektar ++ [153], an open source spectral ﬁnite element code, to
compute wave propagation in the surrogate model. Simulations were run for twenty
cardiac cycles to allow the outlet boundary conditions to reach periodicity in all cases.
Results from the last cardiac cycle were used for subsequent analysis.

5.3.8

Aortic tissue histology and analysis

The inclusion of histological images was intended to serve as a qualitative check
on the quality of the multi-modality based segmentation. Following in vitro testing,
aortic segments were ﬁxed in formalin in a slightly pressurized (10 mmHg) and axially stretched state, then stored in ethanol until paraﬃn-embedded, sectioned at 5
µm, and stained with Movat’s pentachrome (MOV), as per standard protocols. Serial
aortic sections from proximal, middle, and distal regions of the lesion were digitally
scanned at 20X magniﬁcation. Histological sectioning at multiple locations revealed
variations in both geometry and microstructure that should have been captured in the
lumen-thrombus-wall segmentations. That said, histological sections along the axis
of the sample were placed spatially based on an optimization of the various components in a given cross section. Comparisons of lumen, wall, and thrombus area were
made between histological images and discrete axial cross-sections of the segmented
domains, whereby placement of histological images was determined by minimizing
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this diﬀerence in areas. Placement of the histological sections was conducted by the
same person following this optimization scheme. Grading of histological sections by
a pathologist was not included as this was beyond the scope of the study and artifacts arising from processing the sections for histology disallow direct comparisons of
geometry.

5.4

Results

5.4.1

Dissection results in rapid changes in geometry

The initial dissection event was responsible for much of the localized enlargement experienced by the aorta (Figure 5.3). Eﬀective maximum diameter increased
57±9% (n=4), from 1.19±0.11 mm at baseline (day -1) to 1.87±0.24 mm on the
day of diagnosis (day 0), which was signiﬁcantly diﬀerent (p<0.01). Likewise, total
volume increased signiﬁcantly during this ﬁrst day (from 7.65±2.05 mm3 on day -1
to 19.73±3.54 mm3 on day 0; p<0.01), but much less so (a further 26±9%) over the
subsequent week (from day 0 to 7) for those mice with marked lesions, namely M2 to
M4.
Evolving eﬀective maximum diameter nevertheless correlated well with evolving
total volume and thrombus volume from day 0 to day 7 (Figure 5.4). Lesions in mice
M2 to M4 also exhibited a loss of true lumen volume from baseline to day 0 (-52±28%,
or a total of 4.01±1.66 mm3 ). Although this initial reduction did not reach statistical
signiﬁcance (p=0.2), it was partially oﬀset within one day by a volumetric increase of
38±22%, perhaps due to retraction or compaction of the thrombus. Indeed, by day
7 the true lumen volume had recovered up to 70±23% of its original (pre-dissection)
value. Although all mice presented with some enlargement of the SAA proximal
to the celiac branch, M1 did not show any luminal reduction, signs of intramural
delamination, or thrombus formation. Instead, the true lumen volume increased by
25% at day 0 and 51% by day 7, while the total lesion volume increased only negligibly
(<1%) after initial expansion but without developing an aneurysmal shape.
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5.4.2

Dissections increase aortic stiﬀness and alter hemodynamics leading
to acute but evolving thrombus

Consistent with morphologic assessments, PW Doppler measurements revealed
marked diﬀerences in blood ﬂow before and after the dissection (Figure 5.5). Mice
presenting with a dissection-related false lumen and thrombus (M2 to M4) exhibited
a signiﬁcant initial increase in blood ﬂow velocity at the site just proximal to the
intimal opening into the dissection (172±12% increase in mean velocity from baseline
to day 0), which appeared to result from the reduction in the true lumen in that
region (cf. Figure 5.3). Such increases reduced partially (to 49±8%) over the subsequent week, consistent with the partial recovery in true lumen volume. Intramural
thrombus had variable sizes and growth depending on the lesion analyzed, but it
constituted at least 66±13% of the total volume during the ﬁrst week (Figure 5.3;
online Supplemental Movie I). Only for the largest lesion (M4) did the outer wall of
the lesion appreciably expand as the thrombus grew in volume. Serial US scans of
M4 show an increase in thrombus deposition and complex ﬂow patterns after day 0
(online Supplemental Movie II). M1 showed a diﬀerent behavior, with a decrease in
mean velocity (-46%) soon after detecting a modest focal widening of the SAA that
did not lead to intramural thrombus. This reduction persisted through the ﬁrst week
of development. Color Doppler Data also provided important qualitative information
on the ﬂow dynamics, such as the presence or absence of recirculating ﬂow. For example, we identiﬁed recirculating ﬂow in the false lumen of M3 using Color Doppler
(online Supplemental Movie III).
In vivo structural stiﬀness, evaluated by M-mode US, showed a consistent tendency across the four mice (Figures 5.5.c and 5.5.d). Cyclic circumferential strain in
the middle of the aneurysms for animals M2 to M4 decreased signiﬁcantly (83±24%
reduction; p<0.05) from 16±4.6% to 2.7±0.8% soon after dissection and remained
reduced (40±9% reduction between days 0 and 7). Cyclic circumferential strain in
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the same region, SAA, of M1 also dropped sharply on day 0 (80% reduction) and
remained reduced.

5.4.3

Multi-modality reconstructions compare well with histology

Dissected aneurysms present complex morphologies, with regions of blood ﬂow
within the false lumen delineated from regions ﬁlled with thrombus and bounded
by non-uniformly thickened aortic walls. The resolution oﬀered by 3D US alone
often did not provide suﬃcient detail to capture such complexities, which would
prevent suitable reconstructions of the domains needed for detailed hemodynamics
simulations.
Combining in vivo 3D US with in vitro OCT imaging enabled detection of the
main morphologic transitions characterizing each lesion, which diﬀered markedly in
terms of total false lumen volume as well as by regions of free-ﬂowing blood versus
thrombus. After reconstructing the four geometries, we compared our segmentations
qualitatively to histological images for the same specimen taken at three diﬀerent
locations to assess morphology as a function of axial position. Notwithstanding ubiquitous shrinkage and distortion of cross-sections in histological images, Figure 5.6
shows that our segmentations agreed qualitatively with histology for all four vessels (M1 to M4), including regions without dissection, dissections with false lumens,
and dissections with merged lumens. Most importantly, regions with thrombus were
captured well by the OCT imaging.

5.4.4

Advantages of 3D US-OCT

Segmentation of 3D US images allows one to delineate major features of a dissection (cf. Figures 5.1 and 5.6), including total volume and true lumen volume [67]
and to coarsely diﬀerentiate wall, thrombus, and open false lumen. Enriching the US
images with information provided by the OCT images, with a 7 µm spatial resolution,
improved our overall segmentation markedly, particularly when discerning diﬀerent
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regions composing the intramural cavity. Table 5.1 compares measurements obtained
using 3D US images acquired at day 7 (segmentation performed using Vevo LAB software) with results obtained using our combined US+OCT approach (segmentation
performed using the code SimVascular after co-registration and processing of the images). We normalized these results by the length of the considered volumes because
measurements taken using the combined approach were typically limited to shorter
samples due to the tissue cannulation required by the mechanical testing informed
OCT imaging.
Discrepancies between the two methods were modest but not negligible for assessments of true lumen volume (average normalized error of 8.1±2.0%), dissection
region (12.6±15.2%), and total lesion (7.7±5.3%). Diﬀerences were much more pronounced, however, for measurements delineating regions within the intramural cavity
(i.e., false lumen and thrombus). As expected, relative diﬀerences between volume
measurements inferred using 3D US and OCT techniques were small, with only two
exceptions that fell outside the 95% conﬁdence intervals (Figure 5.7). While 3D US
provides reliable estimates of lesion volume, more than volume is needed for a clear
description of these complex pathologies (i.e., false lumen geometry). Thus, the increased resolution of the combined US-OCT approach allowed us to demarcate better
the false lumen boundaries, even allowing detection of a small (0.08 mm3 ) volume
for M2 that was not visible on 3D US images but was evident with histology. This
demarcation is in contrast to previous studies that have used US alone and have not
been able to delineate the composition of the aortic wall or the inner and outer aortic
diameters [84].

5.4.5

Hemodynamic simulations agree well with measurements

Combining high-resolution OCT data of the dissection and nearby vasculature
morphology with time-averaged Doppler US data of the inlet and outlet ﬂows through
all relevant major branches within the abdominal aorta resulted in improved mouse-
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speciﬁc models of the hemodynamics. Table 5.2 shows prescribed mouse-speciﬁc inlet
ﬂow rates and optimal values for resistance and capacitance (determined using the
1D wave propagation model; cf. Figure 5.2) used as boundary conditions for the
hemodynamic simulations.
We then compared velocity waveforms measured using PW Doppler (cf. Figure 5.5) with those predicted by our 3D simulations (Figure 5.8). While the inlet
boundary condition was prescribed at the proximal aorta, the outlet conditions at
the celiac, superior mesenteric, right renal, and left renal branches were optimized using the aforementioned 1D wave propagation model to match the US measurements
(i.e., good agreement was expected). To evaluate further the quality of the simulations, we also compared velocity waveforms proximal to the dissection that were not
used to inform the simulations; agreement was always strong. For visual purposes,
we show 3D renderings of the velocity magnitude at systole and diastole for all four
mice in Figure 5.8. Overall, M1 and M3 showed the best and worst agreements with
measured data, respectively, but results at all locations were reasonable. Goodness
of ﬁt values evaluated as correlation coeﬃcients between predicted and measured
waveforms ranged between 0.86 at the celiac branch of M2 to 0.98 for M3 proximally
to the lesion. The average correlation coeﬃcient at all of the probed locations was
0.94±0.04.

5.4.6

3D US-OCT based simulations of false lumen ﬂow

Suprarenal abdominal aortic dissections are known to diﬀer morphologically in
terms of lesion size, extent of thrombosis, and overall spatial enlargement even when
evaluated at similar times of AngII infusion [154]. Rather than base our study on
the days post-surgery, we screened mice for initial aortic expansion and focused on
a ﬁxed short-term period after the initial diagnosis (7 days). Our combined 3D USOCT approach allowed us to capture lesion-to-lesion diﬀerences with high spatial
detail (Figure 5.7) and to visualize and model complex hemodynamics (Figure 5.9;
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online Supplemental Movies I and III). Table 5.3 lists general characteristic features
of the four lesions, ordered based on the Daugherty classiﬁcation (Type I, II, or III
lesion) and the presence and size of a false lumen [141]. The last group of rows
provides average hemodynamic indices and changes in blood ﬂow velocity predicted
by the hemodynamic simulations. The very low values of time-averaged wall shear
stress (TAWSS) in the false lumen (82±12% lower than in healthy segments of the
SAA) indicate signiﬁcantly perturbed hemodynamics.
Figure 5.9 shows the evolution over a cardiac cycle of color-coded vortical (λ2 )
distributions on longitudinal cross-sections for the four lesions, M1 to M4. Shown
overlapped are streamlines seeded from points lying on the false lumen oriﬁce area or,
for M1, immediately proximal to the dilatation. λ2 is deﬁned as the second largest
eigenvalue of the tensor
S 2 + Ω2

(5.3)

where S and Ω are, respectively, the symmetric and the antisymmetric part of the
spatial velocity gradient tensor, L, which can be written [155, 156]:
L = ∂v/∂x

(5.4)

Regions where λ2 is negative are of potential interest because they can indicate the
presence of vortical ﬂows, which are bounded by regions of high shear and enclose a
local pressure maximum. High ﬂuid shear in turn can activate platelets [157].
Most of the vortices in the true lumen occupy a relatively stable position throughout the cardiac cycle. This ﬁnding is particularly evident in M1, where no major
recirculation event occurs. The presence of a false lumen in M2, M3, and M4 lesions seems to facilitate the formation of vortical structures that persist within the
dissection cavity for large parts of the cardiac cycle. While the dynamics, duration,
and migration patterns of these vortices seem to vary from case to case, the negative λ2 regions always form initially close to the proximal end of the false lumen
opening. Figure 5.9 also shows snapshots of EKV measurements acquired at day 7
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post-diagnosis. For qualitative comparison with the simulated results, a digital image
correlation based particle tracking algorithm was applied to the EKV images and red
arrows indicate directions of blood ﬂow in the imaging plane.

5.5

Discussion
Given the increasing usage of mouse models for vascular studies, it is not sur-

prising that many papers now report hemodynamic simulations. Indeed, advances
in diﬀerent imaging modalities - especially high-frequency US, magnetic resonance
imaging (MRI), and micro-CT - have enabled investigators to build mouse-speciﬁc
geometric models for both 1-D and 3-D simulations. For example, Greve et al. [158]
used phase-contrast and time-of-ﬂight MRI (4.7 T) to build 3-D models of the hemodynamics within the normal murine infrarenal abdominal aorta and showed that
mean wall shear stresses are much higher in the mouse (approximately 8 Pa) than
in humans (approximately 0.5 Pa). Resolution was reported to be on the order of
117 µm (i.e., in-plane voxels approximately 0.0117 cm). Feintuch et al. [159] used a
Vevo 770 US system (FUJIFILM VisualSonics), with a stated resolution of approximately 100 µm (lateral) by approximately 65 µm (axial), to inform models of the
hemodynamics within the murine aortic arch. They further showed a good correspondence between US and MRI measured volumetric ﬂows in the arch and major
branches. Huo et al. [160] combined PW Doppler US, to measure mean velocities in
the ascending aorta, with both a perivascularly placed ﬂowmeter, to measure ﬂows
in the abdominal aorta, and micro-CT images of plastic casts of the entire murine
aorta, to extract geometric information. Spatial resolution was not given although
the signiﬁcant ﬁgures reported would imply approximately 10 µm. Plastic casts, injected at 100 mmHg, are yet diﬃcult to make reliably and the reported values for key
vessels diﬀer considerably from values reported by others (e.g., left common carotid
diameter of approximately 640 µm versus 490 µm reported by Suo et al. [161] and 460
µm by Trachet et al. [114]). Amirbekian et al. [162] used MRI, with a stated spatial

56
resolution of approximately 69 µm X 69 µm, to build computational models of the
abdominal aorta, whereas Trachet et al. [114] combined micro-CT with a theoretical
resolution of 46 µm, to obtain arterial geometries, and US (Vevo 2100), to obtain
information on ﬂows needed to prescribe boundary conditions.
Whereas the aforementioned studies focused on imaging-based models for computing normal hemodynamics, both US [84, 162] and MRI [63, 66, 85] have also been
used to assess lesion growth or wall strain in the AngII infusion model of dissecting
aneurysms. Favreau et al. [84] used high-frequency US alone, which did not allow
them to ”accurately diﬀerentiate between the intraluminal and extraluminal aortic
wall.” To the best of our knowledge, only Ford et al. [86] have built mouse-speciﬁc
US imaging-based models of hemodynamics within such lesions. Their study was
carried out using a single-element transducer with an equivalent 40 µm axial and 90
µm lateral spatial resolution (RMV704 transducer, Vevo770). They reported spatiotemporal results for TAWSS, oscillatory shear index (OSI), and relative residence
time, but focused largely on vorticity. They concluded that ”maximum remodeling
occurs in the areas where vortical structures are located, which in turn result in the
greatest ﬂuctuations in shear stress” (i.e., OSI). They acknowledged, however, that
they did not model the separate outlet branches, they did not have subject-speciﬁc
inlet ﬂow waveforms, and that higher resolution imaging ”would have been desirable.” Indeed, there was no delineation of freely ﬂowing versus clotted blood in the
false lumens. Based on this brief survey, we concluded that prior geometric models
of the murine vasculature have been built on data from either in vivo or combined in
vivo, in situ, and in vitro imaging with spatial resolutions ranging from approximately
40 to 120 µm. The spatial resolution of our US system (Vevo2100) is the same as
used by Trachet et al. [114] and thus reasonable for modeling the major aortic vessels. We suggest that ﬁne details inherent to a dissecting aneurysm demand increased
resolution.
Here we have introduced a combination of moderate resolution (approximately
40 µm) in vivo anatomical and functional US imaging with high resolution (approxi-
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mately 7 µm) in vitro OCT imaging to build computational models of complex dissecting aneurysms in the suprarenal aorta. We monitored mice noninvasively for initial
aortic expansion and obtained early in vivo data of lesion morphology, composition,
and hemodynamics. In this way, we were able to construct the ﬁrst detailed models
of ﬂow within the false lumen of a dissected murine suprarenal abdominal aorta for a
spectrum of lesions ranging from mild to severe. We conﬁrmed that expansion occurs
abruptly in the vicinity of a focal dissection and that growth can be either minimal
or gradual over the short term after this initial event. In vitro images were obtained
only after reproducing in vivo mechanical loading conditions, namely restoring the
axial stretch and imposing a transmural pressure of 80 mmHg. Multi-modality images were co-registered using native ﬁducial markers and veriﬁed qualitatively via
comparison with standard histological images; even open versus thrombotic false lumens were delineated and modeled well. The associated computational hemodynamic
model was further informed by subject-speciﬁc measured inlet ﬂows and optimized
RCR-Windkessel outlet parameters that enabled ﬂow waveforms in all of the major
outlet vessels to be described reasonably well. After ensuring that ﬂows matched well
in a region not used to inform the computational model, we relied on our simulation results to analyze vortical structure behavior throughout the cardiac cycle. Our
analyses suggested that a false lumen cavity is necessary for the formation of major
recirculating events and vortices initially form at the proximal end of the false lumen
opening.
We note that there were some challenges and limitations in this study. Abdominal gas diminishes US image quality and was occasionally present when imaging.
This issue was notable on day 7 at the distal end of the lesion for M4, making detailed US-based segmentation of the open false lumen and thrombus diﬃcult. We
overcame this problem by using morphological and compositional image data derived
from OCT and histology. In general, US data with minimal artifacts allowed us to
delineate regions with free-ﬂowing blood from thrombus; however, the superior resolution of OCT was necessary to conﬁrm and model the detailed composition of the
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dissected region. There can also be noise in M-mode measurements, which particularly impacts the magnitude of the lowest percent strain values. OCT has limitations
in depth of penetration, which can reduce our ability to visualize the thickest arterial
walls. Our custom US-OCT co-registration, however, was able to enhance penetration and our ability to discriminate structural features within the lesions. We do not
have a secondary imaging comparison (i.e., MRI or micro-CT) of the volume measurements; however, our prior US and MRI imaging studies reveal similar volumetric
measurements for other comparable lesions [63, 67, 85]. The volume/length values of
the lesions investigated previously fall within a similar range as those presented here
(1 to 3 mm2 ). The commercially available US system we used in the present study
has been validated extensively, suggesting that our volume estimates for total lesion,
true lumen, and false lumen are precise. Lastly, the assumption of a rigid wall in the
hemodynamic simulations introduces systematic errors, particularly in predicted wall
shear stress values. It is well known that rigid wall simulations tend to overestimate
wall shear stress magnitude in areas of relatively simple hemodynamics (e.g., preaneurysmal SRA) while they underestimate wall shear stress in regions of stagnation
(e.g., surface of dissection cavity). We took great care to acquire and inform the model
with velocity information at all branching vessels. Therefore, we are conﬁdent that
our simulations of observed general behavior (vortex formation and development) are
reliable, and of great interest for understanding intra-lesion hemodynamics.
In summary, complex vascular lesions in mice, such as dissecting aneurysms that
cause abrupt aortic expansion and complex intramural channels, exhibit ﬁne structural heterogeneities that are important when computing the hemodynamics to identify possible causative biomechanical metrics. Notwithstanding advances in US, MRI,
and micro-CT, combining in vivo imaging data with high resolution imaging data
obtained in vitro using OCT can provide much-improved geometric models for computational simulations. Computational models of the hemodynamics, in turn, are
essential for providing information needed to characterize better the relationships
between hemodynamics, wall growth and remodeling, and disease progression.
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Fig. 5.1.: Combined 3D US-OCT imaging technique. By co-registering ﬁducial markers at easily recognizable locations (e.g., branch ostia), we obtained high-resolution
merged datasets that provided morphologic detail suﬃcient to delineate diﬀerent regions of vasculature in and near the dissection. Left and middle images show illustrative sections. A reconstructed vessel with a suprarenal dissecting abdominal aortic
aneurysm (red), including an enclosed false lumen (FL) and intramural thrombus (T)
is shown on the right (blue). res = resolution; US = ultrasound; OCT = optical
coherence tomography.
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Fig. 5.2.: One-dimensional (1D) surrogate model of wave propagation. This 1D model
for mouse M3 (right) was built by extracting centerlines from the reconstructed 3D
geometric model (left). The solution of the 1D wave propagation via a spectral ﬁnite
element method was used in a derivative-free optimization scheme to compute optimal
outlet capacitance values to match measured velocity waveforms at the outlets. PA
= proximal abdominal aorta; CA = celiac artery; FL = false lumen of the dissection;
SMA = superior mesenteric artery; RRA and LRA = right and left renal artery; IA
= infrarenal abdominal aorta; Cx = capacitance for vessel x.
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Fig. 5.3.: Aortic volumes before dissection and during ﬁrst week after diagnosis. (a)
Representative segmentation results of 3D US images for mouse M3. (b) Average
changes in volume across diﬀerent regions within each of the four lesions (M1 to M4).
(c) Volume changes over time for all four mice studied (M1 to M4). Total volume of
the lesion includes true lumen, false lumen, and thrombus; volume for the dissected
region includes false lumen and thrombus. A thickened vessel wall without thrombus
is present in M1. NA = no measurement made due to interference from bowel gas in
US images (see image of M4 in Figure 5.9)
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Fig. 5.4.: Maximum AAA expansion over time. (a) Axial B-mode images of M3 at
baseline, day 0, and day 7. Maximum cross-sectional area was measured to estimate
the change in eﬀective maximum diameter of the suprarenal aorta. 1 mm scale. (b)
Time-varying changes in eﬀective maximum diameter (EMD). (c) The relationships
between EMD and total AAA volume/length as well as EMD and thrombus volume/length are shown at days 0, 1, 3, 5, and 7 relative to the ﬁrst observation of
dissection / disease. In panels (b) and (c), average values ± standard error are shown
for M2, M3, and M4. For panel (c), total AAA and thrombus measurements have R2
values of 0.89 and 0.53, respectively. V = ventral; L = left.
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Fig. 5.5.: Evolution of average velocity and wall displacement waveforms as assessed
by US measurements before and during the ﬁrst week after diagnosis. (a) True lumen
centerline velocity waveforms were averaged over 20 or more cardiac cycles. Measurements were acquired just proximal to the location of the oriﬁce of the dissection
at baseline (day -1), at diagnosis (day 0), and one week after diagnosis (day 7). (b)
Evolution of mean velocity at the same location for all mice during the ﬁrst week of
development. (c) Wall displacement waveforms measured near the point of maximal
aortic diameter prior to and after (days 0 and 7) dissection. (d) Evolution of the
cyclic circumferential Green strain at the same location for the dissected aneurysmal wall during the ﬁrst week of development. NA = no measurement made due to
interference from bowel gas in US images.
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Fig. 5.6.: 3D Solid models reconstructed with our multi-modality technique and compared at key cross-sections. Co-registered 3D US (grey), OCT (red) datasets, and histological sections (Movat stain) taken at approximately the same location are shown.
Note that thrombus stains red in Movat, elastin black, and collagen brown-grey. cc
- coronal section; ax1- proximal axial cross-section; ax2 middle axial cross-section,
ax3 distal axial cross-section, ax representative axial cross-section for M1, which
exhibited little axial variation. Note that the cannula used in the OCT studies is
visualized in part in the cross-sectional views (inner red circle). White scale bar =
1 mm; black scale bar = 500 µm. Recall Figure 5.1 where OCT and US images are
shown separately for the same sections.
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Fig. 5.7.: Bland-Altman plot showing relative diﬀerences between volume measurements obtained with US and US+OCT techniques for diﬀerent regions. The values
0.5(VU S + VU S+OCT ) on the x-axis are normalized so that the mean for each region
equals 1. Note the large discrepancies in relative diﬀerences of the false lumen volumes, for which the US+OCT technique can likely resolve the morphology at higher
detail.
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Fig. 5.8.: Volume rendering and mean velocity waveforms for computational simulations for mice M1 to M4. Color-coded simulations display the velocity magnitude at
systole (left) and diastole (right). Simulated velocity waveforms (solid lines) are also
compared to ultrasound measurements (dashed lines) at all major inlets and outlets
as well as at an intermediate proximal location used to validate, and not inform, the
model.

67

Fig. 5.9.: Comparison of hemodynamic simulations with EKV snapshots for mice
M1 to M4. Color-coded λ2 distributions in lateral cross-sections (left) show evolving vortical structures throughout a cardiac cycle. Overlapped in red are selected
streamlines (tangents to computed velocities). EKV snapshots (right) are overlapped
to representative trajectories tracked using a digital image correlation algorithm. The
white asterisk denotes a region of bowel gas obstruction.
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Fig. 5.10.: Average systolic, diastolic, and mean arterial blood pressures (n=4) before and after pump implantation. Systolic pressure rose to 169±26 mmHg at day
12 post-surgery (i.e., day 4 on average post-diagnosis) from 117±34 mmHg before
implantation (p =0.05).

US
US+OCT
US
US+OCT
US
US+OCT
US
US+OCT

6.8
3.8
9.5
8.4
8.3
7.8
10.5
8.6

True Lumen
1.04
0.99
0.69
0.74
0.61
0.66
0.43
0.71

Total Lesion
1.82
2.14
2.01
2.06
2.62
2.76
3.22
3.58

Volume/Length (mm2 )
Dissection False Lumen
0.77
0
1.14
0
1.33
0
1.31
0.01
2.02
0.26
2.09
0.17
2.79
0.05
2.87
0.88

Thrombusa
0.77a
1.14a
1.33
1.30
1.75
1.92
2.74
1.99

All volume measurements (5 rightmost columns) are normalized by the corresponding lesion length because part of the
sample was excluded via tissue cleaning and cannulation prior to OCT imaging. True Lumen = volume of the aorta
normalized by length, Total lesion = volume of the whole visible lesion, including true lumen, false lumen, thrombus,
and wall thickness, Dissection = Total lesion - True Lumen, False Lumen = blood ﬁlled volume of the intramural cavity,
Thrombus = Dissection - False Lumen. a Note that M1 did not present either a true dissection or an intramural thrombus
and therefore volume measurements refer to the thickened vessel wall.

M1
M1
M2
M2
M3
M3
M4
M4

Mouse Technique Length (mm)

Table 5.1.: Comparison of length and volume measurements obtained using 3D US images alone versus enriched 3D US+OCT
images
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87.6
65.2
110.4
71.6

Celiac
C
RT
3
(x 10 ) (x 10−6 )
4.84
1.00
2.60
6.39
2.37
13.7
3.27
3.79

SMA = superior mesenteric artery
Q = average inlet ﬂow rate (mm3 s−1 )
RT = terminal resistance (g mm−4 s−1 )
C = capacitance (g −1 mm4 s2 )

M1
M2
M3
M4

Proximal Aorta
Q

SMA
RT
C
3
(x 10 ) (x 10−6 )
2.08
28.9
1.03
266
0.734
299
0.763
78.2

Right Renal
RT
C
3
(x 10 ) (x 10−6 )
1.13
33.1
1.25
120
1.59
111
1.02
25.1

Left Renal
RT
C
3
(x 10 ) (x 10−6 )
3.90
8.68
1.54
119
4.49
31.7
1.73
29.3

Infrarenal
RT
C
3
(x 10 ) (x 10−6 )
0.544
201
1.17
393
0.338
99.6
0.633
196

Table 5.2.: Inlet and outlet boundary conditions used in the ﬂuid dynamic simulations
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Type I = Dilated lumen without thrombus
Type II = Remodeled tissue containing thrombus
Type III = Bulbous remodeled tissue containing thrombus
Type IV = Multiple dilations containing thrombus
TAWSS = time-averaged wall shear stress
OSI = oscillatory shear index
a
Systolic blood pressures measured at day 7 post-surgery
Figure 5.10 shows a complete set of blood pressure measurements

Spectrum of lesions characteristics
M1
Morphologic description at day 7
Daugherty’s classiﬁcation
I
(Type I, II, III or IV)
Presence and size of false lumen
Presence of thrombus
Volumetric thrombus growth
% change in thrombus volume
0%
between days 0 and 7
% change in thrombus length
0%
a
General information
P (mmHg)
160
HR (bpm)
566
4v at stenosis
-26%
Average hemodynamic indices
TAWSS (Pa)
in aorta / dissection
OSI
-

M3
III

+ small
+
+
+
15%
12%
3%
2%
140
145
601
539
27%
45%
0.60
0.22
0.11
0.20

M2
II

+ large
+
20%
5%
120
636
45%
0.56
0.14

M4
III

Table 5.3.: Characteristic features of the four lesions studied (M1 to M4), ordered based on the size of the false lumen at
day 7 following the onset of the dissection
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6. QUANTITATIVE CHARACTERIZATION OF
SUSCEPTIBILITY TO
DISSECTING AAA FORMATION
This chapter contains the contents of a manuscript under preparation. At the time
of deposit, the contents of this chapter were being prepared for submission to a peerreviewed journal.

6.1

Introduction
Aortic rupture is an often fatal consequence of aortic dissections and aneurysms.

The ultimate goal of aortic disease research is to prevent aortic rupture and decrease
the high mortality associated with many types of aortic disease. Research eﬀorts towards novel treatment strategies [94,163] and biomarkers [164,165] have been ongoing
for many years, but there has been less emphasis on early versus later disease processes. Understanding early disease processes has the potential beneﬁt of identifying
high risk patients who would beneﬁt from treatment of small aneurysms that do not
meet the current criteria for surgical intervention.
Over the past 20 years, dissecting murine abdominal aortic aneurysms (AAAs)
induced via angiotensin II (AngII) [41, 59] have become a valuable model for studying focal aortic dissection and expansion as well as intramural thrombus formation.
These pathological features are often found in the thoracic aorta of humans with
acute aortic syndrome [166]. Conversely, human AAAs typically form below the level
of the kidneys and exhibit slow expansion with gradual circumferential vessel wall
destruction and remodeling [122]. The AngII-induced dissecting AAA model also has
features of atherosclerosis, inﬂammation, and extracellular matrix (ECM) remodeling,
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all of which are found in human aortic disease. While these have been well studied
via histology and molecular analysis at a mature stage, it is diﬃcult to study the
early pathology of this model without knowing if and when an animal has already
developed a focal dissection and aortic expansion. These lesions appear to develop
suddenly on the order of minutes to hours [64] and therefore determining the earliest
time point in development is diﬃcult. With increased access to small animal imaging
systems, including micro-computed tomography [167], high-ﬁeld magnetic resonance
imaging [63], and high-frequency ultrasound (US) [84, 168], there have been multiple noninvasive longitudinal in vivo imaging studies examining experimental aortic
disease models. However, AngII-induced dissecting AAAs show variable incidence
rates [154], have abrupt and variable formation, and are not diagnosable without
imaging prior to animal sacriﬁce. Some studies have thus misinterpreted AAA prevalence [107] and possibly overlooked or misidentiﬁed lesions depending upon the criteria
used.
Our prior imaging and characterization work with the AngII model motivated
the present study. We previously tracked in vivo changes in aortic morphology and
biomechanics in AngII-infused apoE −/− mice over 28 days [67]. While we measured
progressive volumetric growth on average, we noted large diﬀerences, particularly in
timing and volume, among animals. For this reason, we conducted a second study
to investigate in more detail progression on an animal-speciﬁc basis [169]. We ﬁrst
repeatedly screened the animals between days 3 and 21 post-implantation in order to
determine the timing of initial aortic expansion for each mouse. Not all animals developed a dissecting AAA while others experienced sudden aortic rupture and died. We
imaged each animal with a dissecting AAA for an additional 7 days after identiﬁcation of initial aortic expansion. This study demonstrated that four lesions (identiﬁed
on days 6 and 9 post-implantation) were heterogeneous in terms of early volumetric
growth, thrombus deposition, false lumen ﬂow, and hemodynamic metrics, including
time averaged wall shear stress, oscillatory shear index, and formation of vortices.
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For the present study, we implemented a daily ultrasound screening approach to
diagnose aortic dissections within 24 hours of formation on an animal-speciﬁc basis.
Thus, the physiological and molecular factors responsible for vessel wall remodeling
are already active in these lesions. We hypothesize that similar factors in humans
could be responsible for initiation of vessel wall remodeling and play a role in development. Furthermore, this work is of particular interest as the majority of patients
diagnosed with AAAs have aortic diameters less than 5 cm and do not meet the
criteria for surgical intervention. Indeed, understanding early AAA formation and
progression could be helpful to improve translational strategies for the medical treatment of small aneurysms.
Here we compared diﬀerences in early disease initiation and progression among
three experimental cohorts (AngII AAA, AngII No AAA, and Saline) of male apoE −/−
mice at 12 weeks of age at baseline. Based on previous studies [63, 67, 69, 73, 169], we
selected day 10 as the cutoﬀ for screening AngII-infused animals that did not develop
a dissecting AAA (AngII No AAA). We tested the hypothesis that a proinﬂammatory
phenotype and microstructural defects develop in the suprarenal aorta as early as day
3 of AngII infusion and are suﬃcient to induce a dissecting AAA. We also hypothesized
that the suprarenal wall would exhibit reduced circumferential cyclic strain that is
correlated to the dissection severity as seen by histology. Furthermore, based on a
prior study by Usui et al. [46], we investigated whether animals in the AngII AAA
cohort have higher aortic gene expression and activation of IL-1β, as compared to
the AngII No AAA and Saline cohorts. Finally, we investigated whether animals
in the AngII No AAA cohort exhibit an intermediate state of inﬂammation and
ECM remodeling that does not result in full vessel wall breakage. The results of
this work provide a wealth of information at both the gene and tissue levels on the
susceptibility of the suprarenal mouse aorta to dissection formation and initial aortic
expansion. This study has implications for future research on acute aortic syndrome
in humans and to investigate potential biomarkers and treatment strategies for early
aortic disease.
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6.2

Methods

6.2.1

Experimental design

The Purdue Animal Care and Use Committee approved all experiments performed
on animal protocol 130200818. We implanted 20 male apoE −/− C57BL/6J mice
at 12 weeks of age with subcutaneous miniosmotic pumps (Alzet, DURECT Corp,
Cupertino, CA) loaded with either AngII (n=15) or saline (n=5). AngII was loaded
according to animal body weight at a dose of 1000 ng/kg/min for an infusion duration
of 28 days. The mean weight of all animals was 28.3 ± 1.8 g at 12 weeks of age (time
of pump implantation) and 27.9 ± 2.0 g at the time of sacriﬁce (within 10 days after
implantation). All animals were monitored for dissecting AAA development by US
for up to 10 days after pump implantation surgery.

6.2.2

In vivo ultrasound imaging and blood pressure collection

Before implanting pumps (baseline), we collected full US imaging datasets, systemic pressures, and blood serum. Starting at day 3 post-implantation, we screened
the AngII-infused animals daily for the appearance of dissecting AAAs (Figures 6.1
and 6.2). We acquired in vivo US data of aortic size (B-mode), pulsatility (M-mode),
and blood ﬂow dynamics (Color Doppler) using a 50 MHz center frequency transducer (MS700) on the Vevo2100 system (FUJIFILM VisualSonics, Toronto, Canada).
When screening an animal, if both short- and long-axis aortic diameters were the
same the previous day, we collected B-mode, M-mode and Color Doppler scans and
continued screening the following day. If the diameter was larger, we checked whether
the aortic wall motion was substantially reduced (M-mode) and whether there was
any disturbance in blood ﬂow along the suprarenal aorta (Color Doppler). If an aortic
dissection was visible, we collected a full imaging dataset (2D and 3D B-mode, Mmode, Color Doppler, PW Doppler, and EKV) and sacriﬁced the animal (AngII AAA
cohort). By day 10, if an aortic dissection was not observed, as would be evidenced by
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a substantial increase in diameter alongside vessel stiﬀening and disturbance in blood
ﬂow, we collected a full imaging dataset and sacriﬁced the animal (AngII No AAA
cohort). For saline-infused mice, we collected imaging data at day 10 only and then
sacriﬁced the animals (Saline cohort). In addition to baseline assessment, we collected
blood pressure measurements between days 5 and 9 after pump implantation.

6.2.3

Animal sacriﬁce and tissue collection

We sacriﬁced animals within 24 hours of each animal-speciﬁc endpoint. Both the
suprarenal and infrarenal aortic segments were harvested. Each segment was divided
via axial cuts into approximately equal halves and then frozen for histology and gene
expression analysis. For animals without dissecting AAAs, we grossed a total vessel
length of approximately 8 mm.

6.2.4

Histology and immunohistochemistry

We embedded the proximal halves of suprarenal and infrarenal segments in optical cutting temperature (OCT) compound and froze the tissues over dry ice-cooled
isopentane prior to storage at -80◦ C. For each slide, 5 µm-thick non-sequential cryosections (200 µm apart) were collected starting from the distal end of each segment.
Sections were ﬁxed with methanol and stained using Hematoxylin and Eosin (H&E),
Movat’s Pentachrome (MOV), Martius, Scarlet and Blue (MSB), Verhoeﬀ Van-Gieson
(VVG), and Masson’s Trichrome (MTC). Standard immunohistochemistry (IHC)
was performed using the following primary antibodies: rabbit anti-mouse MMP-9
(ab38898; Abcam), goat anti-mouse IL-1β (AF401NA; R&D systems), rat anti-mouse
neutrophil NIMP-R14 (ab2557; Abcam), and rat anti-mouse macrophage F4/80 (Cl:A31; Bio-Rad). Sections were developed using peroxidase substrate 3,3’diaminobenzidine (DAB), producing a brown stain in areas with immunoreactivity.
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6.2.5

Total RNA extraction, dilution and pooling

Total RNA from the distal half of each aortic segment was extracted with TRIzol
reagent and treated with DNase I prior to elution from spin columns using the Zymo
Directzol RNA Miniprep kit and the RCC-5 columns. One µL of RNase inhibitor
was added to each extracted sample. We veriﬁed sample quality by absorbance (Nanodrop, Thermo Scientiﬁc, Waltham MA). We puriﬁed samples with suspected DNA or
protein contamination using RNA Clean and Concentrator-5 kit (Zymo, Irvine CA).
For inclusion in cDNA library construction and real-time polymerase chain reaction
(RT-PCR) assays, biological samples were required to have 260/230 and 260/280
absorbance ratios of greater than 1.7. We used ﬂuorimetry (Qubit 2.0, Thermo Scientiﬁc) to determine sample concentrations.
Prior to cDNA library construction, we made 6 experimental pools, each consisting
of either suprarenal (n=3-7) or infrarenal (n=2-5) aortic segments from one of the
three cohorts. A given pool was comprised of samples with equal amounts of total
RNA. Absorbance readings were taken after dilution and pooling and clean-up was
performed if necessary.

6.2.6

cDNA library construction, puriﬁcation and quantiﬁcation

We used the Ovation RNA-Seq System for mouse (NuGEN, San Carlos CA) designed for low input (10-100 ng) total RNA. Optional DNA fragmentation and concentration were not performed but the libraries were depleted of ribosomal RNA using insert dependent adaptor cleavage (InDA-C) primers. We qualitatively assessed
the ampliﬁed libraries using the Agilent Bioanalyzer 2100. If unreacted adapters
or adapter dimers were present, we used Ampure beads to purify. Absolute sizeadjusted concentrations for the libraries (8.2 to 87 nM) were determined using the
KAPA Library Quantiﬁcation Kit (KAPA Biosystems) and average library sizes from
the electropherograms.
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6.2.7

mRNA sequencing and bioinformatics

mRNA sequencing (RNA-seq) was performed at the Purdue University Genomics
Core Facility. Samples were equally pooled and clustered on an Illumina Rapid Chemistry ﬂowcell. One and a half lanes were loaded and samples were sequenced in singleread mode for 61 base reads on an Illumina HiSeq 2500. The total number of reads
per library were between 33.8 and 42.4 million.
We performed subsequent expression analysis on Galaxy (usegalaxy.org). RNAseq reads were quality-ﬁltered with FastQC, aligned with HISAT2, and assembled
using the Cuﬄinks protocol [170]. We performed bioinformatics analysis for diﬀerentially expressed genes (DEGs) and gene ontology (GO) terms using Advaita Bios
iPathwayGuide (http://www.advaitabio.com/ipathwayguide). This software analysis tool implements the Impact Analysis approach that takes into consideration
the direction and type of all signals on a pathway, the position, role and type
of every gene, etc., as described by Draghici et al. [171]. We also used Qiagen
Ingenuity Pathway Analysis (IPA) to generate networks and functional analyses
(https://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis/) for the
6 datasets as well as for publicly available data published by Rush et al. [48] (Gene
Expression Omnibus Accession GSE12591). We utilized DAVID (Database for Annotation, Visualization and Integrated Discovery; https://david.ncifcrf.gov) to cluster
genes by similar functional annotations collected from multiple sources, including
GO terms, and to calculate an enrichment score for each functional annotation cluster [172, 173].

6.2.8

Real-time PCR and relative gene expression analysis

Remaining total RNA was ﬁrst reverse-transcribed to cDNA (Applied Biosystems High Capacity cDNA Reverse Transcription Kit, Waltham MA). We used ZEN
double-quenched probes with FAM dye (Integrated DNA Technologies, Coralville,
IA) to assay mir223, Il1b, Eln, Col4a3, Mmp9, and Ppia. We ran assays in dupli-
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cate using 0.5 ng of DNA template with the following cycling conditions: 1) 95◦ C
for 3 minutes; 2) 45 cycles of 95◦ C for 15 seconds and 60◦ C for 1 minute (Applied
Biosystems 7500 System). After validating constitutive expression of Ppia across experimental conditions, we selected it as a housekeeping gene for normalizing target
gene expression levels. We performed relative quantitation of gene expression (n=3-7
per cohort) by the ΔΔCT method and used either the AngII No AAA or Saline cohort
as a comparator group.

6.3

Results

6.3.1

Angiotensin II infusion leads to abrupt dissecting AAA
formation over a range of diagnosis days

Of the 15 AngII-infused animals, 7 developed a dissecting AAA by day 10 (47%;
AngII AAA cohort), 5 did not develop a dissection (33%; AngII No AAA cohort),
and 3 became moribund or experienced an aortic rupture (20%; excluded from study).
None of the 5 saline-infused mice (Saline cohort) developed a dissecting AAA. Figure
6.1 provides the breakdown of animal numbers and timing used to assign each animal.
Two animals were diagnosed as early as day 3 post-implantation; none were diagnosed
on either of the two ﬁnal days (days 9 and 10). Classiﬁcation to the AngII AAA or
AngII No AAA cohort was made according to the daily check of B-mode, M-mode and
Color Doppler data (see Methods). B-mode and M-mode data acquired at baseline,
a screening day, a diagnosis day and day 10 are provided for visual reference (Figure
6.2).
Systolic blood pressure (SBP) for AngII-infused animals increased modestly but
signiﬁcantly from baseline values after at least 6 days of infusion (Table 6.1). Baseline
values ranged from 86 to 108 mmHg across all animals (AngII AAA: 97.4 ± 5.7 mmHg;
AngII No AAA: 101.8 ± 4.5 mmHg; Saline: 95.6 ± 6.7 mmHg). SBP increased to
124.5 ± 8.5 mmHg (n=8 of the 12 animals) and the averages were similar between the
AngII AAA and AngII No AAA cohorts (118.7 ± 2.1 mmHg and 128 ± 9.1 mmHg,
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respectively). The change in SBP was minimal for the two animals measured in the
Saline cohort.

6.3.2

Angiotensin II infusion leads to volumetric growth and strain reduction regardless of dissecting AAA status

Average volume/length of the suprarenal aorta increased signiﬁcantly from baseline for both the AngII AAA (140.9 ± 29.4%; p<0.001) and AngII No AAA (66.7 ±
16.4%, p<0.05) cohorts. Interestingly, there were statistically signiﬁcant diﬀerences
among all three cohorts at the animal-speciﬁc endpoint: AngII AAA and AngII No
AAA (59.6 ± 8.7%; p<0.001); AngII AAA and Saline (122.5 ± 15.2%; p<0.001);
and, AngII No AAA and Saline (39.4 ± 5.0%; p<0.05) (Figure 6.3.a).
Volume/length values increased by more than 100% in six of the seven AngII AAA
animals (108 - 217%). Individual values for the combined false lumen and thrombus
volume (i.e., total dissecting AAA volume minus true lumen volume) normalized by
the ﬁnal dissecting AAA length were similar across animals and constituted a large
proportion of the total AAA volume (80±6%; 73 - 89%). For the seven dissecting
AAAs, the axial lengths varied between 4.41 mm and greater than 14.92 mm (9.72 ±
3.18 mm) and the distal end of the lesions was observed both above and below the right
renal artery. For one case, abdominal gas obscured the aorta proximal to the superior
mesenteric artery at the endpoint and volume was estimated in this region. Volumetric
renderings calculated from 3D ultrasound segmentations (Figure 6.3.b) reveal the
diﬀerences in vessel expansion among the three cohorts (Figure 6.3.c). By comparison,
upon postmortem inspection of the vessels in situ, the intermediate expansion and
absence of a false lumen in the AngII No AAA cohort were not apparent.
We also investigated the diﬀerences in diameter and vessel strain among the three
cohorts. Based on time-averaged inner diameter values, we noted larger diﬀerences
between peak systole and end diastole in the AngII No AAA and Saline cohorts as
compared to the AngII AAA cohort (Figure 6.3.d). In the examples shown, the
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diﬀerence between peak systolic and end diastolic inner diameter was 52 µm (AngII
AAA), 82 µm (AngII No AAA), and 144 µm (Saline). As with volume/length, average
EMD was signiﬁcantly diﬀerent among all three cohorts (Figure 6.3.e). Average EMD
was 35.5 ± 3.2% larger for the AngII AAA cohort relative to the AngII No AAA cohort
(p<0.001). Relative to the Saline cohort, average EMD was 58.1 ± 5.1% larger for
the AngII AAA cohort (p<0.001) and 16.7 ± 1.4% larger for the AngII No AAA
cohort (p<0.05). The smallest EMD measurement for the AngII No AAA cohort
(1.34 mm) was the same as the largest measurement for the Saline cohort and, not
surprisingly, these two cohorts had the closest ranges of values. Average CCS values
were signiﬁcantly diﬀerent among all three cohorts (AngII AAA: 3.07 ± 1.68%; AngII
No AAA: 7.63 ± 2.89%; Saline: 14.42 ± 3.19%) (Figure 6.3.f). For the AngII AAA
cohort, average CCS was 78.7 ± 46.4% lower relative to the Saline cohort (p<0.001).
For the AngII No AAA cohort, average CCS was reduced (-47.1 ± 20.7%; p<0.05)
compared to the Saline cohort and was 59.8 ± 39.8% higher (p<0.05) than that for the
AngII AAA cohort. The individual strain values for the AngII No AAA cohort fall in
a range of values (4.5 to 11.3%) that overlaps with values from the other two cohorts.
Furthermore, we found CCS to be inversely correlated with EMD (linear regression
with slope of -13.11 and Pearson correlation coeﬃcient of -0.82). However, for larger
diameter aortas some strain values trended below the 95% conﬁdence interval (Figure
6.3.g).

6.3.3

Inﬂammation- and extracellular matrix-related genes are
diﬀerentially expressed among experimental cohorts

We found 346 signiﬁcant DEGs for at least one of the experimental contrasts in
the suprarenal aorta datasets. We applied two lines of evidence for DEG selection: 1)
genes with a fold change of greater than 1.5 and 2) an adjusted p-value (false discovery
rate) of less than 0.1. The highest number of unique DEGs (183) was found for the
comparison with the highest expected contrast (AngII AAA vs. Saline) and the lowest
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number (16) for the comparison with the lowest expected contrast (AngII No AAA
vs. Saline; Figure 6.4.a). These genes displayed three obvious patterns of expression
across the experimental contrasts as seen on a heat map (Figure 6.4.b). The ﬁrst
pattern (approximately 87% of DEGs) shows upregulated expression in the AngII
AAA cohort, little to no downregulated expression in the AngII No AAA cohort, and
downregulated expression in the Saline cohort. The second pattern (8% of DEGs)
shows downregulation for the AngII AAA cohort, little to no change in expression
for the AngII No AAA cohort, and upregulation for the Saline cohort. Finally, the
third pattern (5% of DEGs) shows little to no change in expression for the AngII
AAA cohort, upregulation for the AngII No AAA cohort, and downregulation for the
Saline cohort.
Of the three possible comparisons, we focused in particular on the AngII AAA
vs. AngII No AAA contrast (Tables 6.2 and 6.3). Among the most upregulated
genes were primarily ones encoding for inﬂammatory factors and receptors (e.g., Il1r2,
Csf3r, Ccl2, Pf4, and Ccr1 ) and matrix metalloproteinases (Mmp8 and Mmp9 ). We
also measured upregulation of an inﬂammation-related microRNA (mir223 ). Among
the most downregulated genes were ones encoding ECM proteins (e.g., Optc, Col4a3,
Eln, Mfap4, and Fmod ), cytoskeletal proteins (e.g., Tnnt2 and Cnn1 ), as well as
both a peptidase inhibitor (Serpina1d ) and a disintegrin and metalloproteinase with
thrombospondin motifs (Adamts8 ). Not surprisingly then, several genes relevant to
inﬂammation and ECM remodeling are diﬀerentially expressed in the AngII AAA
cohort. We veriﬁed the diﬀerential expression levels of selected DEGs by real-time
PCR (Figure 6.4.c). These genes followed the same pattern of expression as seen
with RNA-seq analysis. mir223 was signiﬁcantly upregulated in the AngII AAA
cohort relative to each of the other cohorts while Il1b was signiﬁcantly upregulated
in both the AngII and AngII No AAA cohorts. Eln was signiﬁcantly downregulated
for the AngII AAA cohort relative to the AngII No AAA cohort, but signiﬁcantly
upregulated for the AngII No AAA cohort relative to the Saline cohort. For the AngII
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AAA cohort, Col4a3 had a signiﬁcantly lower level of expression relative to each of
the other cohorts, which was opposite to Mmp9 expression levels.

6.3.4

A subset of diﬀerentially expressed genes related to
inﬂammation and extracellular matrix remodeling shows
diﬀerential expression in the suprarenal aorta

We focused the list of DEGs further by excluding genes with diﬀerential expression
in the infrarenal aortas of the same animals. Forty-ﬁve of the 346 genes had no diﬀerential expression in the infrarenal aortas from the AngII AAA cohort. Of these genes,
8 were upregulated and 1 was downregulated relative to the AngII No AAA cohort.
Genes that encode for a member of a lymphocyte diﬀerentiation antigen superfamily
expressed on neutrophils (Ly6g6d ), a plasma membrane eﬄux pump (Abcb1b), and
a proteoglycan involved in protease storage in hematopoietic cells (Srgn) were all
upregulated. Interestingly, Il1rn, which encodes for the IL-1 receptor antagonist, was
also upregulated. Sost, a gene that encodes for a Wnt/β-catenin pathway inhibitor,
was downregulated.
Relative to the Saline cohort, 34 genes associated with multiple processes were
upregulated, including inﬂammation (e.g., Pf4, Mpeg1, and Tnfrsf1b), reactive oxygen
species production (Cybb), blood pressure regulation (Ednrb), thrombus formation
(F13a1 and Emilin2 ), extracellular matrix remodeling (e.g., Mmp14, Adam12, and
Col8a1 ), and leukocyte recruitment (Gcnt1 ). Lrg1, a gene encoding a member of the
leucine-rich repeat family of proteins, was upregulated and is a potential pathological
biomarker. Individual genes associated with second messenger production (Adcy5 ),
connective tissue assembly (Thsd4 ), immune homeostasis (Cytl1 ), and smooth muscle
cell function (Synpo2 ) were downregulated.
Ten of the 346 genes had no diﬀerential expression in the infrarenal aortas from
the AngII No AAA cohort. Eight genes were upregulated relative to the Saline cohort,
such as Sst, which encodes for a hormone with immunosuppressive and antiprolifera-
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tive eﬀects. Other genes were not well annotated or have no supporting evidence to
date for aortic expression. Relative to the AngII AAA cohort, Ly6g6d and Hsd3b1
were downregulated.

6.3.5

Suprarenal aorta Il1b expression is associated with aortic size and
strain

We analyzed the association between aortic gene expression and US-derived metrics of size (EMD and Volume/Length) and strain (CCS). As these metrics are related
to vessel structure and pulsatility, we ﬁrst evaluated the relationship to expression
levels of Mmp9, which can cleave elastin, collagen, and other proteins (Figure 6.4.d).
For 5 of the 7 AngII AAA animals, lower ΔCT values (i.e., higher relative expression)
of Mmp9 were associated with larger EMD and lower CCS. For AngII No AAA and
Saline animals, higher ΔCT values were associated with lower EMD and higher CCS.
Overall, regression lines showed good correlation (Pearson correlation coeﬃcients of
-0.89, -0.94, and 0.86 for EMD, volume/length, and CCS, respectively). Mmp9 expression levels, however, overlapped for the AngII No AAA and Saline cohorts.
We then evaluated the relationship to Il1b, which had a wider range of expression
values (Figure 6.4.e). Intermediate ΔCT values of Il1b for the AngII No AAA animals
were also associated with moderate vessel expansion and strain reduction. Regression
lines again showed good correlation (Pearson correlation coeﬃcients: -0.94, -0.92, and
0.87).

6.3.6

Regulation of neutrophil migration, neutrophil chemotaxis,
monocyte chemotaxis, blood coagulation, and cellular
extravasation are enriched in dissecting AAAs

The DAVID system calculated high enrichment scores for the AngII AAA cohort
in functional annotation clusters related to the immune system, chemokines, and
secreted and extracellular factors. Relative to the Saline cohort, high enrichment
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scores for the AngII No AAA cohort included functional annotation clusters related to
secreted and extracellular factors, the extracellular matrix, immune system processes,
and collagen.
Statistical ranking of biological process GO terms revealed that multiple inﬂammatory processes were highly enriched in the AngII AAA cohort compared to both
the AngII No AAA and Saline cohorts (Figure 6.5). Interestingly, multiple GO
terms identiﬁed regulation of neutrophils as a signiﬁcant biological process. Furthermore, GO terms for cytokine production, mononuclear cell migration, and monocyte chemotaxis were enriched, supporting the expected presence and recruitment of
monocytes/macrophages. In line with US ﬁndings and necropsy images of thrombus in all 7 AngII AAA lesions, processes for blood coagulation were also enriched.
Collagen metabolism and cellular extravasation were uniquely enriched in the AngII
AAA cohort as compared to the AngII No AAA cohort. The AngII No AAA cohort was uniquely enriched for processes including wound healing, response to reactive oxygen species, and negative regulation of peptidase activity. GO term analysis with the subset of 45 suprarenal-speciﬁc AngII AAA DEGs produced a shorter
list of biological processes that included regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298), positive regulation of tumor necrosis
factor production (GO:0032760), inﬂammatory response (GO:0006954), and immune
response (GO:0006955).

6.3.7

Comparative analysis of diﬀerentially expressed genes after acute
and chronic angiotensin II infusion

We compared DEGs in the present study with those identiﬁed in a chronic (28day) AngII infusion study [48] (GEO accession GSE12591). 44 DEGs were found
to be unique to the present study, including factors involved in inﬂammation (e.g.,
Ccl6, Ccr2, and Arg1 ), reactive oxygen species generation (e.g., Ncf1 and Lyz2 ), and
regulation of transcription (Spi1 ).
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6.3.8

Early dissecting AAA histology and immunohistochemistry

Early dissecting AAA histology with MOV and MSB staining revealed focal elastin
breakage and intramural thrombus development in proximity (Figure 6.6). MOV,
MSB and MTC staining showed greater adventitial collagen in the infrarenal aorta
as compared to the suprarenal AngII AAA. Early dissecting AAA IHC showed abundant staining for macrophages and neutrophils in the adventitia (Figure 6.7). In the
dissected region, neutrophils were abundant and MMP-9 and IL-1β were observed
along the interface with the elastic lamina. By comparison, the infrarenal aorta had
little positive staining.

6.4

Discussion
We investigated susceptibility to dissecting AAA formation by diﬀerentiating the

morphological, biomechanical, inﬂammatory, and matrix remodeling changes occurring in mice with and without aortic dissection. After screening animals by US for
aortic dissection, we collected imaging data within 24 hours of diagnosis or at the
ﬁnal study endpoint, day 10 post-implantation, and classiﬁed animals to one of three
experimental cohorts. We separated the dissection-prone (suprarenal) and dissectionresistant (infrarenal) regions of the abdominal aorta for histology, IHC, and gene expression analysis. We found that AngII exposure led to aortic vessel expansion and a
reduction in vessel wall CCS. Neutrophil and mononuclear cell inﬁltration, increased
IL-1β expression, and ECM remodeling occurred to varying degrees dependent on
whether an aortic dissection was identiﬁed in vivo. The following discussion focuses
on further insights into the tissue- and gene-level diﬀerences identiﬁed in the AngII
AAA and AngII No AAA cohorts.
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6.4.1

Aortic expansion and vessel wall pulsatility in the AngII No AAA
cohort

Aortic vessel expansion and reduction in CCS occurred in all AngII-infused animals regardless of whether a dissecting AAA formed. This result was surprising
for the AngII No AAA cohort because signiﬁcant changes in EMD or volume/length
were not expected in the absence of a dissection. We attribute increases in EMD
(42 ± 4%) and volume/length (67 ± 16%) in this cohort to the hypertensive effect of AngII on aortic remodeling [174]. The percent increase in EMD was below
the 50% threshold used to deﬁne human AAAs for four of the ﬁve AngII No AAA
murine aortas. It is not unexpected that past studies using morphometry to measure diameter in depressurized aortas post-sacriﬁce conclude that there is no aortic
enlargement in AngII-infused animals where no focal expansion was observed. More
accurate measurements from the in vivo US data in this study suggest that there is
moderate vessel enlargement, especially after 10 days of AngII infusion. Despite the
uniform lengths used for volumetric segmentation in this cohort, the percent increase
for volume/length values ranged between 30 and 109%.
Endpoint CCS was less than 10% for three of the ﬁve animals in the AngII No
AAA cohort (4.5, 6.4 and 8.3%) and overlapped with animals in the other two cohorts. Future work could include acquisition of 4D US data to analyze global and
region-speciﬁc vessel wall strain in these aortas [175]. This more sophisticated analysis would provide insight into where along the suprarenal aorta of AngII-infused
animals we detect the largest reductions in pulsatility. During daily screening of
AngII-infused animals, we collected M-mode data to assess whether average CCS was
reduced. We made measurements at three diﬀerent axial locations but did not identify abnormally low CCS in any animals prior to development of dissecting AAAs.
Using 4D image analysis for this purpose however may have better predictive capability by correlating regional strain heterogeneity with potential for focal medial elastin
breakage, dissection, and aortic expansion.
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6.4.2

Aortic gene expression of matrix remodeling enzymes and
extracellular matrix proteins

We found high levels of suprarenal MMP expression, including Mmp8 and Mmp9,
in the AngII AAA cohort. MMP-8, expressed in neutrophils as well as ECs, VSMCs,
and macrophages, cleaves native type I and type III ﬁbrillar collagens [176–178].
Mmp8 expression could be indicative of the presence of inﬁltrating neutrophils [179]
or synthesis by adventitial mesenchymal cells [180]. Wilson et al. have shown that
MMP-8 activity is signiﬁcantly higher in areas where aortic rupture has occurred in
human AAAs [181], supporting the theory that its speciﬁcity towards proteolysisresistant ﬁbrillar collagens is necessary for excess collagen breakdown and eventual
rupture [100].
There is clearly a signiﬁcant role of MMP-9 in aortic disease initiation. Based
on the ﬁnding of high circulating levels of MMP-9 in patients with acute aortic dissection, Kurihara et al. determined that AngII induced the release of MMP-9 from
neutrophils, which led to acute aortic dissection in the thoracic aorta of mice that
were administered a lysyl oxidase inhibitor [182]. In the present study, we observed
abundant adventitial staining of MMP-9 that was co-distributed with macrophages
and neutrophils. As well, there was evidence of MMP-9 and IL-1β staining between
the media and dissected region (Figure 6.7). Future work could include colocalization analysis of MMP-9 and neutrophils in the dissected region and investigation of
whether MMP-9, beyond its role in elastin degradation [125], is suﬃcient to activate
IL-1β during initial aortic expansion. This is an inﬂammasome-independent mechanism of activation that was proposed by Schoenbeck et al. in an in vitro study 20
years ago [183], but has not been fully elucidated in vivo with cardiovascular disease
models.
Interestingly, Eln expression was highest in the AngII No AAA cohort. Transcription of elastin precursors may be stimulated by a co-expressed gene, such as
Tgfb2 [47]. The diﬀerential expression of elastin-associated ECM proteins, such as
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Fbn1 and Mfap5, suggests ongoing vessel wall remodeling or repair processes involving elastin microﬁbril assembly [184]. AngII AAA tissue revealed focal regions
of complete transmural rupture. For AngII No AAA tissue, we observed intermittent and small microstructural defects to the elastin lamellae. While further work
is needed, this initial analysis suggests increased Eln expression may be protective
against AngII-induced dissections.
Various collagen types showed diﬀerential expression and were classiﬁed based on
related functions to other ECM and secreted factors. For the AngII AAA cohort,
Col3a1, Col5a2, Col8a1, and Col12a1 were signiﬁcantly upregulated relative to the
Saline cohort. According to DAVID analysis for this cohort comparison, Col8a1 (type
VIII alpha 1 collagen) was functionally classiﬁed (i.e., shared multiple annotation
terms in common) with genes encoding for complement pathway factors C1q [185]
and C1qtnf6 [186], as well as Emilin2 (elastin microﬁbril interfacer 2) [187]. Additionally, several ECM and secreted factors were functionally classiﬁed together: Emilin2,
Mfap4, Mfap5 (microﬁbrillar-associated protein 5) [188], Sost (sclerostin, see section below), Optc (opticin) [189], Angptl4 (angiopoietin-like 4) [190], and Cthrc1
(collagen triple helix repeat-containing protein 1) [191]. Increased local synthesis of
EMILIN2 may be occurring in dissecting AAA formation; its proposed role in thrombus formation and contraction would be of interest to explore [187]. We also noted
downregulation of Fmod, which encodes a ﬁbrosis-promoting collagen-associated protein, ﬁbromodulin. Dense collagen formation is increased by ﬁbromodulin, which
promotes collagen cross-linking activity [192]. This is in agreement with our histology which revealed a thin layer of adventitial collagen in the AngII AAA tissue.
Compensatory collagen deposition and remodeling may not be present at this early
stage (cf. [67, 169]). For the AngII No AAA vs. Saline comparison, DAVID analysis
grouped together ﬁve genes encoding diﬀerent collagen types (I, V, VI, XII, and XIV),
all of which were signiﬁcantly upregulated. Furthermore, genes encoding biosynthetic
enzymes for collagen, including Lox, Plod2, and P4ha3, as well as Fmod were measured at higher levels in the AngII No AAA cohort. Analysis of AngII No AAA tissue
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is ongoing to compare collagen distribution and abundance relative to AngII AAA
tissue after acute and chronic AngII infusion.

6.4.3

Inﬂammatory gene expression signatures

We identiﬁed inﬂammatory signatures for the AngII AAA and AngII No AAA
cohorts based on diﬀerential gene expression. GO terms for inﬂammatory cell recruitment and regulation predominated for the AngII AAA cohort, while both inﬂammationpromoting and -resolving processes (e.g., wound healing and negative regulation of
cytokine production) were identiﬁed for the AngII No AAA cohort. We measured signiﬁcantly higher levels of IL-1β in AngII-infused animals with the largest diﬀerence
relative to the Saline cohort (∼60-fold increase; p<0.001). Nlrp3, which encodes for
a sensor protein that is part of the inﬂammasome complex, was signiﬁcantly upregulated relative to the AngII No AAA cohort as was the signaling receptor for IL-1
(Il1r1 ) relative to the Saline cohort. Relative to the AngII No AAA cohort, however,
higher expression of some factors involved in blunting IL-1-mediated inﬂammation
(Il1r2 and Il1rn) suggests a more complex picture is at a play within this early stage
of dissection.
Martin et al. demonstrated that IL-1R2, a decoy signaling receptor for IL-1, is
constitutively expressed on mouse neutrophils and after an inﬂammatory stimulus,
can be shed from the membrane and then re-expressed [193]. Thus, a soluble form
of this receptor is able to sequester free IL-1. IL-1 receptor antagonist, encoded
by Il1rn (IL-1Ra), is required in excess of IL-1β in order to inhibit IL-1-induced
processes and is secreted by the same cells producing IL-1β [194, 195]. Il1rn was
found to be a DEG in the AngII AAA suprarenal dataset that was absent in the
infrarenal dataset, suggesting that a counterbalancing inﬂammatory response may
be active in the suprarenal aorta. IPA canonical pathway analysis for the AngII
AAA vs. Saline comparison identiﬁed ”inﬂammasome pathway” as activated (z-score
2.236; p=0.0035), similar to what we calculated using publicly available results from
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the chronic (28-day) AngII infusion study [48] (z-score 2; p=0.0164). ”IL-1 signaling”
had borderline activation (z-score 1.897; p=0.0012) based on diﬀerential expression of
Il1r1, Myd88, Fos, Ikbke, Irak3, Nfkbia, Gnai3, and Adcy5, and is more signiﬁcant as
compared to the chronic study (z-score 1.342; p=0.321). IL-1β staining on AngII AAA
tissue was observed along the edge of the dissected region and within the true lumen
(Figure 6.7.b). Taken together these data suggest that the AngII AAA cohort shows
upregulated expression of factors involved in the inﬂammasome pathway and IL-1β
signaling, but that inhibition or sequestration of IL-1β may explain the moderate
protein expression seen by IHC.
Neutrophils and macrophages are the inﬂammatory cell types we found to show
high and consistent enrichment in the AngII AAA cohort according to iPathwayGuide
and IPA. A neutrophil marker (Ly6g6d ) was a DEG in the suprarenal dataset that
was absent in the infrarenal dataset. DAVID analysis grouped this gene together
with Tnfrsf23 (tumor necrosis factor receptor superfamily, member 23), Bst1 (bone
marrow stromal cell antigen 1) [196], and Dpep2 (dipeptidase 2). Other granulocyte
markers (e.g., Csf3r ) and factors promoting neutrophil chemotaxis (e.g., Pf4 and
Cxcl2 ) [197, 198] were also diﬀerentially expressed relative to the other two cohorts.
IPA identiﬁed fMLP signaling in neutrophils” (12 genes; z-score 3.464; p=2.36E-4)
and ”inﬁltration of neutrophils” (45 genes; z-score 3.015; p=1.2E-25) as activated for
the AngII AAA vs. AngII No AAA comparison. These processes had lower activation
z-scores for the chronic study (z-scores 1.89 and 1.358, respectively). Activation of
fMLP signaling in neutrophils raises the possibility that mitochondrial chemotactic
peptides released upon cell injury and necrosis [199] are responsible for neutrophil
recruitment to the suprarenal aorta and contribute to the inﬂammatory response
[200]. Ly6G+ neutrophil staining on AngII AAA tissue was abundant throughout the
adventitia and dissected region (Figure 6.7.c). Thus, gene- and tissue-level results
indicate that neutrophil recruitment and inﬁltration are particularly active in the
suprarenal aorta following acute AngII infusion.
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Key chemokines and chemokine receptors on monocytes/macrophages showed
high expression (e.g. Ccl2, Ccr1 and Ccr2 ) in the AngII AAA cohort. A previous study has already demonstrated that the chemokine CCL2 and interaction with
its macrophage receptor (CCR2) can drive vascular inﬂammation and ECM remodeling through coordinated eﬀects with adventitial ﬁbroblasts [72]. ”Production of
nitric oxide and reactive oxygen species in macrophages” (z-score 2.985; p=4.28E10), ”Fcγ receptor-mediated phagocytosis in macrophages and monocytes” (z-score
4.082; p=1.25E-16), and ”CCR5 signaling in macrophages” (z-score 2.236; p=0.0202)
were all found to be signiﬁcantly activated for the AngII AAA vs. AngII No AAA
comparison in the suprarenal dataset. For the infrarenal dataset, only ”Fcγ receptormediated phagocytosis in macrophages and monocytes” was found to have borderline
activation (z-score 2; p=0.0571). These three pathways showed very similar activation z-scores (3.051, 3.606, and 2.236, respectively) for the chronic infusion study.
Total (F4/80+ ) macrophage staining on AngII AAA tissue was abundant throughout
the adventitia as well as in the periadventitial space (Figure 6.7.d). These results
conﬁrm previous studies [64,68,69,201] that macrophages are an active inﬂammatory
cell type in the suprarenal aorta and underscore their involvement in early dissecting
AAA development.

6.4.4

Potential disease regulator biomarkers and therapeutic targets

Among the highest expressed DEGs in the AngII AAA cohort was mir223 (∼7-fold
average increase relative to AngII No AAA cohort; p=0.0023), a micro-RNA which
is released possibly exclusively by hematopoietic cells [202]. This potential biomarker
and therapeutic target requires further investigation in light of recent publications on
multiple inﬂammatory diseases, including chronic obstructive pulmonary disease [203]
and cancer [204]. Chu et al. recently proposed a mechanism for how miR-223 may
be released from leukocytes and platelets into circulation and lead to vascular injury
that causes Kawasaki Disease, a genetic condition associated with increased systemic
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vascular inﬂammation that can cause coronary artery aneurysms [202]. Kin et al.
have shown that relative to healthy patients, higher mir223 expression is detectable
in human AAA tissue and is accompanied by lower expression in AAA patients’
plasma [205].
The most downregulated DEG in the AngII AAA cohort (Sost; ∼15-fold average
decrease relative to AngII No AAA cohort; p=5E-5) had no diﬀerential expression in
the infrarenal dataset. Sost encodes sclerostin [206], a secreted glycoprotein that can
inhibit Wnt signaling, leading to decreased expression of osteopontin (Spp1 ), MMP2, and MMP-9 [207]. Our ﬁndings of signiﬁcant downregulation of Sost accompanied
by upregulated Spp1 and Mmp9 are in line with the recent study by Krishna et al.
which demonstrated the potential of sclerostin to inhibit dissecting AAA formation
and atherosclerosis and provided evidence for epigenetic silencing of sclerostin in
human AAAs [207].
A secreted glycoprotein found in serum that is thought to be involved in diﬀerentiation of neutrophils (leucine-rich α2-glycoprotein, LRG) [208] showed upregulated
gene expression in both the AngII AAA and AngII No AAA cohorts relative to the
Saline cohort (∼5.5- and ∼3-fold increase, respectively). Previous work has demonstrated that IL-1β, IL-6, and TNF-α can induce LRG secretion from diﬀerent cell
types into serum [209,210]. These two studies among others have proposed that LRG
could be used as a circulating biomarker for inﬂammatory states. For this reason, it
would be of interest to validate whether LRG has higher circulating levels in animals
that do develop a dissecting AAA.

6.5

Summary
We have quantitatively characterized the early pathology seen in AngII-infused

apoE −/− mice through a comparison with animals that did not develop a dissection
and saline-infused controls. We found that the aorta expanded and had reduced vessel
wall strain regardless of whether a dissecting AAA formed. Biological processes re-
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lated to neutrophil and mononuclear cell inﬂammation, regulation of IL-1β signaling,
ECM remodeling, and blood coagulation were all enriched in the AngII AAA cohort.
Processes such as wound healing, response to muscle activity, and response to reactive
oxygen species were enriched in the AngII No AAA cohort relative to saline controls
alongside intermediate gene expression of pro-inﬂammatory and matrix remodeling
genes. Histology revealed the presence of focal elastin breakage, accumulation of
ﬁbrin and red blood cells, and relatively little adventitial collagen in early stage dissecting AAAs. Furthermore, we observed abundant macrophages and neutrophils in
the adventitia of AngII AAA tissue and IL-1β and MMP-9 in proximity to medial
elastin and the dissected region. Ongoing work for this study is to assess the severity
of elastin defects and collagen remodeling in all tissues.

Fig. 6.1.: Experimental design for in vivo monitoring and sacriﬁces of cohorts. Twelve animals were assigned to either
cohorts 1 (AngII AAA) and 2 (AngII No AAA) depending on whether a dissecting AAA was identiﬁed by day 10 after
AngII pump implantation. Three additional animals were monitored but excluded from the study. Two of these animals
were moribund and one experienced an aortic rupture before ﬁnal full US datasets were collected. Five animals in cohort 3
(Saline) were implanted with saline-ﬁlled pumps.
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Fig. 6.2.: Example B-mode (left) and M-mode (right) images at baseline, an intermediate screening day, and endpoints for each cohort
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Fig. 6.3.: Volumetric growth and reduction in vessel wall strain occur with AngII
infusion regardless of dissecting AAA status. a) Volume/length diﬀerences across
AngII AAA, AngII No AAA and Saline cohorts. 2-way ANOVA with Sidak multiple
comparisons. Open circles: baseline; Black circles: endpoint. b) 3D B-mode data for
an AngII AAA mouse. V: ventral; Cr: cranial c) Suprarenal aorta renderings show
complex morphology in a leftward-expanding lesion for AngII AAA, moderate vessel
expansion for AngII No AAA, and a healthy vessel for Saline cohorts. d) Example
time-averaged inner diameter measurements (± standard deviation) over a cardiac
cycle. Diﬀerences between peak systolic (Ds ) and end diastolic (Dd ) inner diameter
are shown. e) EMD at the animal-speciﬁc endpoint. 1-way ANOVA with Tukey
multiple comparisons. f) CCS at the animal-speciﬁc endpoint. 1-way ANOVA with
Tukey multiple comparisons. g) Correlation between vessel strain and aortic diameter.
CCS is plotted against corresponding EMD (triangles: Saline cohort; squares: AngII
No AAA cohort; circles: AngII AAA cohort). Linear regression (solid line) and 95%
conﬁdence interval (dashed lines) are shown. Slope: -13.11. Correlation coeﬃcient
(r): -0.82. p=0.0001. *p<0.05; **p<0.001
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Fig. 6.4.: a) 346 signiﬁcant diﬀerentially expressed genes (DEGs) selected (fold change
greater than 1.5 and adjusted p-value less than 0.1). Number of unique DEGs (dashed
line circles) is largest for highest expected contrast and smallest for lowest expected
contrast. b) Heat map and dendrogram of DEGs across comparisons. Raw z-scores
are color-coded. Scale bar: upregulated (red), downregulated (green) and no change
(black). c) Real-time PCR validation of selected DEGs (mir223, Eln, Col4a3, Mmp9,
and Il1b). Ppia was ﬁrst validated and used as a housekeeping gene for each run.
Each assay was run in duplicate and 3 to 5 biological replicates per cohort were used.
One-way ANOVA with Holm-Sidak multiple comparisons of each cohort (*p<0.05;
**p<0.001). d, e) Linear regression analysis between diameter, strain and gene expression of Mmp9 and Il1b across three cohorts. EMD (mm) and CCS (%) are plotted
against corresponding ΔCT values (housekeeping gene-corrected cycle threshold values for a target gene) for (a) Mmp9 and (b) Il1b. Note that higher ΔCT values
represent longer ampliﬁcation and lower relative expression. Correlation coeﬃcients
(r): -0.89 (Mmp9 vs. EMD); 0.86 (Mmp9 vs. CCS); -0.94 (Il1b vs. EMD); 0.87 (Il1b
vs. CCS). Solid symbols: EMD; Open symbols: CCS; Circles: AngII AAA cohort;
Squares: AngII No AAA cohort; Triangles: Saline cohort. Two data points from the
AngII AAA cohort were excluded as outliers.

Fig. 6.5.: Enriched gene ontology (GO) terms for biological processes (adjusted p<0.05 using weight pruning correction)
identiﬁed using Advaita Bio’s iPathwayGuide. Examples of enriched biological processes are shown.
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Fig. 6.6.: Movat’s Pentachrome (MOV) staining of a dissecting AAA shows focal breakage of elastin (arrow) and evidence
of cell inﬁltration. Adventitial collagen staining (yellow/green; arrowhead) appears more abundant in the infrarenal aorta.
Martius, Scarlet and Blue (MSB) staining of the same tissue shows an intramural thrombus (asterisk) by positive ﬁbrin
(red) and red blood (yellow) stains in proximity to the focal dissection. Adventitial collagen staining (blue; arrowhead)
appears more abundant in the infrarenal aorta. Scale bars: 500, 200, and 50 µm for low, middle, and high magniﬁcation,
respectively.
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Fig. 6.7.: 3,3’diaminobenzidine IHC of MMP-9 (a), IL-1β (b), Ly6G+ neutrophils (c),
and F4/80+ macrophages (d) of a dissecting AAA (each left image) and the accompanying non-dissected infrarenal aorta (each right image). MMP-9 is co-distributed
with neutrophils and macrophages in the adventitia. In the dissected region (hypocellular region at the bottom of each left image), neutrophils are abundant and MMP-9
and IL-1β are observed along the interface with the elastic lamina (black arrows).
The infrarenal aorta shows little positive staining in the vessel wall. Scale bars: 200
µm.

Baseline SD
SBP
AngII AAA
98
11
AngII AAA
95
10
AngII AAA
103
15
AngII AAA
103
20
AngII AAA
102
7
AngII AAA
93
7
AngII AAA
88
11
AngII No AAA
96
10
AngII No AAA
99
12
AngII No AAA
103
16
AngII No AAA
108
22
AngII No AAA
103
12
Saline
86
20
Saline
102
9
Saline
93
6
Saline
102
12
Saline
95
13

Cohort

Day Post-implantation SD
SBP
6
121
18
6
118
16
7
117
32
7
141
13
6
134
19
9
121
22
6
121
17
7
123
19
7
96
19
5
94
14
4.4
4.1
4.3

6.6
6.5
4.2
3.2
3.8
3.3
-1.4

47
35
17
13
19
11
-8

SD

23
24
14

% Change

SBP: Systolic blood pressure (mmHg); SD: standard deviation
p-values for unpaired two-tailed t-tests comparing baseline and post-implantation values
Dashes indicate that measurements were not collected.

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17

Mouse

26.3

20.4

Mean
% Change

14.3

5.7

SD

0.8565

0.0004

0.0003

p-value

Table 6.1.: SBP rises modestly within 10 days after implantation of AngII-ﬁlled pumps. Animal-speciﬁc SBP values are
shown at baseline (prior to pump implantation) and at a time point post-implantation. Each value is an average from at
least 11 valid runs with measured ﬂow of more than 4 µL/min. The average percent increase in SBP was similar for the
AngII AAA and AngII No AAA cohorts (20 and 26%, respectively) and the increases were statistically signiﬁcant. The
percent change in SBP was minimal for the two animals measured in the Saline cohort.
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Table 6.2.: Top 30 up-regulated genes with associated log2 fold change for AngII AAA
vs. AngII No AAA comparison
Gene name
log2
Hsd3b1
Cyp21a1
Il1r2
S100a8
S100a9
Arg1
Cyp11a1
Chil3
Ppbp
Csf3r
Cyp11b1
Mmp8
Akr1b7
Star
Ccl2
Slfn4
Clec4d
Pf4
Hmox1
Spp1
Cxcl5
Mmp9
Cxcr2
F630028O10Rik,Mir223
Nrgn
Pram1
Clec4n
Ccr1
Cxcl2
Iﬁtm1

fold change
6.03
5.23
5.05
4.94
4.85
4.85
4.77
4.73
4.73
4.60
4.52
4.42
4.42
4.33
4.21
4.16
4.12
4.09
4.07
3.99
3.99
3.97
3.93
3.88
3.70
3.65
3.64
3.62
3.61
3.59
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Table 6.3.: Top 30 down-regulated genes with associated log2 fold change for AngII
AAA vs. AngII No AAA comparison
Gene name
Sost
Tnnt2
1700003D09Rik
Optc
Pgbd1
Serpina1d
Igfbp2
Casq1
Lhx9
Samd7
Drd1
9330102E08Rik
Pnoc
Col4a3
Vax2os
Cnn1
Eln
Mfap4
Rp1l1
Clec3b
Fmod
Adamts8
Chmp4c
Trim71
Ccdc141
Itgbl1
Adamtsl2
Nov
Dusp27
Susd5

log2 fold change
-3.98
-3.97
-3.14
-2.93
-2.73
-2.69
-2.64
-2.56
-2.49
-2.45
-2.44
-2.38
-2.29
-2.27
-2.27
-2.26
-2.24
-2.20
-2.14
-2.12
-2.11
-2.10
-2.07
-2.06
-2.05
-2.05
-2.03
-1.98
-1.96
-1.95
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7. SYNTHESIS
7.1

Overview of research ﬁndings
The AngII model is a powerful experimental model that mimics aspects of human

AAAs and aortic dissection. This dissertation research provides insights into the in
vivo longitudinal development of the model through US-derived measurements and
susceptibility to dissection formation and initial aortic expansion. Aortic volume and
circumferential cyclic strain were useful metrics to track changes in animal-speciﬁc
vessel wall growth and pulsatility over time. Thrombus deposition was informative for
diﬀerentiating the size and composition of dissecting AAAs. Animal-speciﬁc hemodynamic simulations also enabled evaluation of time-averaged wall shear stress, oscillatory shear index, and relative residence time. As compared to mice without aortic
dissections, ones that had newly developed aortic dissections experienced greater aortic expansion, reduced vessel wall strain, and thrombus formation alongside greater
enrichment of proinﬂammatory processes involving macrophages and neutrophils.

7.2

Directions for future research
Future work could address multiple areas that stem from the research presented

here. Longitudinal assessment of hemodynamic metrics would provide further insight
into dissecting AAA growth and remodeling in vivo. 4D US of the suprarenal aorta
to measure regional vessel wall strain could lead to the ability to pinpoint and predict
areas of focal medial elastin breakage. Gene knockout and colocalization studies may
elucidate whether MMPs can activate IL-1β in dissecting AAA development. Blood
serum analysis of inﬂammatory, matrix remodeling or other secreted factors could
enable identiﬁcation of useful circulating biomarkers for screening animals with higher
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susceptibility to dissecting AAAs. Further data mining of the RNA sequencing data
will generate new hypotheses requiring experimental studies to investigate diseaseinitiating factors and test experimental treatments.

7.3

Translational signiﬁcance
Adopting aortic volume and/or vessel wall strain measurements in clinical prac-

tice may have an advantage for screening and following patients that develop small
AAAs that expand lengthwise or rupture. Preclinically validated early aortic disease
biomarkers that are potentially relevant to humans could be screened in at-risk or
diagnosed patients.
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